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Abstract
Bacterial biofilms can form on medical implants and cause serious device-associated infections
that are incurable by conventional antibiotics because of high-level tolerance to antimicrobials.
Common strategies for controlling device-associated infections, such as coating with
antimicrobials and modification of surface properties, can reduce or delay biofilm formation, but
the inhibitory effect can be overcome by bacteria over time, and eradicating mature biofilms
remains challenging. Direct currents (DCs) have been shown to have bactericidal effects and
synergy with conventional antibiotics in concurrent treatment has been demonstrated for killing
biofilm cells. However, these systems require a direct connection between electrodes and a power
source, which requires skin-piercing wiring for current delivery. This is an invasive process that
causes discomfort and can lead to secondary infections. In this study, we developed a new method
to achieve DC treatment wirelessly towards the non-invasive control of device-associated
infections. Pseudomonas aeruginosa PAO1 and Staphylococcus aureus ALC2085 were used as
model organisms to investigate the killing efficacy of wirelessly delivered DC.
In the proof-of-concept experiments, we demonstrate that antibiotic tolerant biofilm cells can be
effectively eradicated by electromagnetically induced DC from a remote power source. For
example, the number of viable P. aeruginosa and S. aureus biofilm cells was reduced by
approximately 3.4 and 2 logs, respectively, after treatment with 60 µA/cm2 of wirelessly delivered
DC using stainless steel electrodes for 6 hours. DC generated with graphite-based TGONTM
electrodes was also effective especially against S. aureus. For example, the viability of P.
aeruginosa and S. aureus biofilm was reduced by 1.4 and 2.5 logs, respectively, after treatment
with the 30 µA/cm2 of wirelessly delivered DC for 3 hours. Synergy in biofilm killing was also

observed between lower level DC and antimicrobials (tobramycin and chlorhexidine for P.
aeruginosa and S. aureus, respectively). These conditions were found safe to both human lung
epithelial cells and mouse fibroblast cells. Additionally, the viability of S. aureus and
Streptococcus mutans biofilms on the denture material were also reduced by 5 and 4 logs,
respectively, by the concurrent treatment with the 28 µA/cm2 of DC and 50 µg/mL chlorhexidine
for 1 hour.
To further evaluate the potential of this technology, we engineered a prototype device after
comparing different device designs with varying shapes, electrode layouts, and electrode materials.
The prototype device based on the selected design demonstrated 1.0 and 2.6 logs of killing of P.
aeruginosa and S. aureus biofilms, respectively, with 6 µA/cm2 of wirelessly delivered DC for 6
h using an ex vivo model with porcine skin. Further in vivo test using a rabbit model showed that
the prototype device inserted under the dermis tissue killed S. aureus biofilm cells by 65 % in vivo
when receiving a magnetic field from outside of the body to generate DC. No tissue damage was
found according to the histological analysis.
The killing mechanism of DC treatment was investigated in this study by comparing the killing
effects of different electrochemical products. The results show that DC treatment using TGON
electrodes killed bacterial cells by generating hypochlorite from the anode; while the DC treatment
using stainless steel electrodes induced Fenton reaction and generated free radicals that have potent
bactericidal effects.
In summary, the findings from this study indicate that wirelessly delivered DC has promising antibiofilm effects on bacterial pathogens, both in vitro and in vivo. To our best knowledge, this is the
first study to report the bactericidal activity of wirelessly delivered DC treatment. With the
capability to kill bacterial biofilm without using a directly connected power source, this platform

technology has potential applications for noninvasive treatment of biofilm infections associated
with orthopedic, cochlear and other implanted medical devices.
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Chapter 1
Motivation and hypothesis

1

1.1 Implant device-associated infections
The application of surgically implanted medical devices is on the rise due to advances in device
design and improvement in patients’ life quality 1. However, device-associated infections remain
challenging despite the improvement in sterilization techniques during the last decade 2.
Approximately 4.3% of the total 2.6 million orthopedic devices implanted in the United States
every year are infected 3. The risk of hearing aid implants (e.g. cochlear and bone anchored implant)
associated infection is also approximately 4%; but more detrimental to younger patients

4, 5

. Such

infections lead to ulcer, swelling or inflammation of affected tissues 6, and further surgeries for
implant relocation, fixation and even explanation 7.
The standard therapeutic approach for controlling and curing the bacterial infection is antibiotic
treatment. Since the discovery of penicillin in the 1940s, antibiotics have saved millions of lives
from microbial infections. However, bacterial pathogenic also developed resistance to all kinds
of commercially available antibiotics, which has become one of the most serious threats to public
health. Based on CDC’s report in 2013, there are at least 2 million people infected by the antibioticresistant strains annually and at least 23,000 people die in the U.S. alone 8. Bacteria have multiple
strategies to survive the killing of antibiotic resistance including acquired mechanism based on
resistant genes and intrinsic mechanisms due to the formation of dormant persister cells and
surface-attached biofilms. Among these factors, biofilms play an important role in recalcitrant
device-associated infections since the abiotic surface of implanted medical devices are fairly
susceptible to microbial adhesion 7 9.

2

1.2 Central hypothesis and specific aims
Due to the high-level antibiotic resistance, biofilm infections present serious challenges to
infection control. Consequently, the use of conventional antimicrobials constantly fails to eradicate
the biofilm cells on the implant surfaces even at high concentrations. Instead, treating biofilms at
sub-lethal levels can promote the development of antibiotic-resistant strains, such as superbugs
that resist all currently available antibiotics.
In 1994, Costerton et al.

10

demonstrated that low-level direct current (DC) had antimicrobial

effects, and DC had synergy with the antibiotic in bacterial killing. This phenomenon, known as
bioelectric effects, provides a new direction for engineering new antimicrobial strategies. However,
the electric current must be delivered by wires in conventional electric treatment, which requires
skin-piercing in clinical application. This could bring the risk of secondary infection and pain or
discomfort. This severely limits the application of electric treatment. Using implantable battery is
an option without skin-piecing, but the capacity of a battery limits the in vivo lifetime of the device
and brings the risk of battery leak. We were motivated to develop a wireless system to deliver
electric current from an external power to the implant device in vivo. We hypothesize that
therapeutic levels of direct electric current (DC) could be delivered from a power source the
medical device wirelessly. To test this central hypothesis and explore the underlying mechanisms,
this study was conducted to systematically investigate the effects of wirelessly delivered DC on
bacterial biofilms using in vitro, ex vivo and in vivo models. The proposed study was carried out
in three specific aims:
Aim 1. To evaluate the effects of wirelessly delivered DC on bacterial biofilms by varying the
electrode materials and treatment conditions and testing the synergy between DC and antibiotics

3

in vitro. P. aeruginosa and S. aureus were selected as model species and treated with the different
levels of wirelessly delivered DC with or without antibiotics. Both graphite-based TGON and
stainless steel coupons were tested as electrode materials. The mechanism of bacterial killing by
DC was investigated by testing the effects of ions, solutions, and redox reactions.
Aim 2. To design a prototype device that integrates the wireless DC delivery and electric treatment
system and evaluate its antimicrobial activities. The design was optimized to reduce the size to fit
in a <30 mm3 case, which is the same as cochlear implants, pacemakers and GI tract stimulators.
The layout of the electrodes was also optimized.
Aim 3. To evaluate the effects of skin tissue on electromagnetic coupling and the killing effects of
the DC treatment device in both ex vivo and in vivo models. The killing effects of the prototype
device on biofilms was evaluated in an ex vivo model with porcine skin as the barrier and an in
vivo model using rabbits. The cytotoxicity to host tissues was also studied by histological analysis.
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2.1 Microbial biofilm formation
Biofilms are a complex structure composed of bacterial cells and an extracellular matrix produced
by the attached cells. Biofilms are constantly formed on implanted biomaterials and medical
devices. When a device is implanted in a host, it is coated quickly coated with proteins such as
fibrin and fibronectin, which provide a better anchor for bacterial adhesion 1. Once a mature
biofilm is established, it is difficult to eradicate due to slow growth and high level of antimicrobial
tolerance 2.
Extracellular polymeric substance (EPS) is a major contributor to the antimicrobial resistance of
biofilm cells, which prevents the common antimicrobial agents from effectively penetrating. This
extracellular matrix is composed of polysaccharide, proteins, nucleotides, and lipids, which could
protect cells from the oxidizing biocides, some antibiotics and metallic cations 3 by retarding the
diffusion or neutralization 4.
Another mechanism of antimicrobial resistance of biofilm cells is its lower metabolic activities of
biofilm cells. While EPS retards penetration of hazardous compounds into biofilm, the nutrients
are also depleted in the biofilm, especially in deep layers, along with the accumulation of toxic
metabolism wastes 5. These factors lead to dormancy of biofilm cells and the formation of persister
cells, a subpopulation with extremely high-level antibiotic tolerance but without genotype changes.
In 1944, Joseph Bigger

6

first found that there was a small but constant subpopulation of

Staphylococcus, which could survive after long-time treatment with high-concentration penicillin
and named this subpopulation “persisters”. Resistant cells didn’t cause significant attention due to
the success of antibiotic therapies until 2000s. Kim Lewis reported persister phenotype in
Escherichia coli 7. Numerous studies have shown that the persister cells formation is not due to

8

genetic mutation but rather phenotypic variants 8-12. When the cells survived were sub-cultured in
the absence of antibiotics and rigorously antibiotic treatment, the new culture exhibits the same
level of antibiotic susceptibility, which indicates it is tolerance, rather than resistance.
2.2 Biofilm formation on the implanted medical devices
Microbial pathogens that cause biofilm-associated infections usually come from the patients’ skin,
surgical equipment or hospital environment 13. The infection may occur immediately after surgery
or during the post-surgery period ranging from several months to years depending on the causative
agents and the patient’s immunity. The standard treatment of such conditions is using antibiotics.
If the antibiotic therapy fails, the patient needs two-step surgeries. This requires explanation,
cleaning the infected area with a high concentration of antibiotics, and implantation of a new
device 14. This procedure is expensive and negatively impacts the life quality of the patient.
Biofilm formation is a dynamic process including initial attachment, microcolony formation,
maturation and dispersion

15

. The concept of “race for the surface” well describes the nature of

biofilm-associated infections on implants; e.g., if bacterial adhesion occurs on implanted
biomaterial before tissue integration, it is difficult to prevent further biofilm formation by host
defense

16

. There are many factors that affect bacteria adhesion, such as the roughness

topography

20-22

, hydrophobicity

23-25

, net charge of the surface

25, 26

17-19

,

and van der Waals forces

between cells and surface 27. Bacterial cells can produce specific proteins and other molecules to
enhance the initial attachment on medical device surfaces 27-29.
After bacterial cells irreversibly attach to the surface, the cells proliferate to form clusters with
multiple layers of cells in mature biofilms. During this stage, the extracellular polysaccharide is
produced, and form an extracellular matrix along with proteins and extracellular DNA

9

28, 30, 31

.

Bacterial cell-cell signaling system, such as quorum sensing (QS) system is also active in the
biofilms, which have major impacts on biofilm formation, motility, and production of EPS 32. For
example, S. aureus uses the Agr QS system to regulate the production of virulence factors that
promote surface attachment and protect the cells from clearance by the host immune system 33.
Along with biofilm maturation, bacterial cells become inactive (e.g. persister formation) or due to
the lack of nutrient and accumulation of toxin

34, 35

. Under certain conditions, biofilm cells may

dispense from the biofilm matrix, and migrate to another location with motility and/or flow 5, 36, 37.
This leads to the spread of infection from the implant site to the bloodstream and other organ
tissues, which can be life-threatening

38, 39

. As a result, even if the patient has received the anti-

infection therapy or new implantation, bacterial cells may come back from surrounding tissues and
cause infection again, leading to chronic infections with recurring symptoms

40

. Most causative

agents of device-associated infections are opportunistic pathogens, consistent with the protection
of biofilms. These species include P. aeruginosa 8, 40, S. aureus 16, 41, Klebsiella pneumonia 42 and
Acinetobacter baumannii 43.
2.3 Representative implant device-associated infections
Dental implants are widely used implanted devices serving for different purposes. Unfortunately,
the human mouth is an ideal environment for microbial growth; e.g. there are approximately 109
bacterial cells of more than 1,000 species in each mL human saliva

15, 44

. Because the dental

surfaces are coated with saliva which contains mucus, varying enzymes and many other
components, such as epithelial cells, lysozyme and secretory IgA

15

, these surfaces are prone to

microbial attachment, growth and the formation of dental biofilms (also known as dental plaques)
in the oral cavity. One pathogen with significance in dental biofilm is S. aureus. Unlike other
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common oral species, such as Streptococcus mutans and Streptococcus gingivitis that produce acid
to cause tooth decay, S. aureus is frequently linked to infections associated with the dental implant
infection 45, 46. S. aureus biofilms cause inflammation of surrounding tissues (e.g. gum), pain, and
may lead to implant failure. Because infections often happen in the deeper site of soft tissue, daily
oral hygiene has limited impact 45.
Orthopedic implants are another type of devices facing challenges by biofilms. The surfaces of
commonly used orthopedic components contain stainless steel, titanium, ceramic, cobaltchromium alloy, hydroxyapatite, and polymethylmethacrylate (PMMA) cement. All these
materials are susceptible to colonization by bacterial cells 47, 48. In general, 34% of infections are
caused by S. aureus, followed by S. epidermidis (32%), and P. aeruginosa (7%) 49. It is alarming
that the Methicillin-resistant S. species (MRSA S. aureus) is fund in increasing cases orthopedic
infections

50

. The conventional strategies to prevent orthopedic implant infections focus on

controlling environmental and personal factors related to the surgical operation. In recent research,
antifouling/antimicrobial techniques have been applied to modify orthopedic materials, such as
bactericidal coating or antifouling surface modification by altering charges, roughness,
hydrophobicity of the implanted materials.
Modern devices, such as cardiovascular implants, cochlear implants, insulin pumps, and GI tract
stimulators, are also susceptible to biofilm-associated infections. Due to their rather short history
of application, there are only a few epidemiological reports about the infections of these electronic
devices; however, the problem is expected to become more serious due to the rapid increase in the
use of electronic implants. Based on the limited data from the recent literature, Staphylococcal
biofilm is still the primary cause

4, 51, 52

, and P. aeruginosa is more correlated with chronic

infections 53. Infections associated these devices could lead to more serious or even life-threatening
11

conditions than orthopedic and dental infection since the implant sites are usually close to
important organs or central nervous system (e.g. brain, heart). As other device-associated
infections, Antibiotic treatment is the primary choice for therapy. If antibiotic treatment fails,
patients have to take surgeries to explant the devices. Because these devices usually have essential
life-saving functions, the surgery of electronic medical devices have higher risks, and thus are
complicated than orthopedic or dental surgery. Those surgeries bring more suffering to patients
due to longer recovery time from the surgical trauma 54.
In summary, biofilm-associated infections have a significant risk for medical implants because
these devices are widely applicable in the human body to improve life quality, facilitate therapies
process or sustain life. High-level resistance to antibiotics of biofilm cells necessitates
multidisciplinary research to develop more and more comprehensive solutions to these challenging
problems.
2.4 Current antifouling and antimicrobial approaches for controlling device-associated
infections
An effective approach to preventing infection is to use materials that have antimicrobial activities.
Some metals have intrinsic bacterial killing activities, such as silver, zinc, and copper. Multiple
mechanisms are involved in bacterial killing. For examples, silver ions can interact with thiol
(sulfhydryl) groups and interfere with the respiratory chain of bacterial cells

55

. Zinc oxides

nanoparticles can cause morphological changes and measurable membrane leakage of bacterial
cells 56. However, the bactericidal effect of metal ions is not highly specific to prokaryotic cells,
which lead to cytotoxicity to host cells

57-59

. Moreover, the corrosion of metal materials in vivo

could accumulate excessive metal ions and possibly precipitates, which have detrimental effects
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on host tissue and organs. For example, silver ions and silver chloride precipitates were found to
have cytotoxicity to red blood cells and human mesenchymal stem cells 57. Although the metals
are not used as bulk for implanted devices, these materials are promising candidates for using in
nanoparticles, hydrogel or bioactive alloys with other non-toxic metal materials. Chitosan is
another biomaterial with promising antimicrobial activities. It is a polycationic polymer compound
derived from chitin. By modifying the chitosan structure, a number of derivatives have been
developed with improved functions 60, 61.
Another strategy for combating device-associated infections is coating the metal (e.g. titanium) or
polymerase material (e.g. silicone, hydrogel) of the device with a bioactive antibacterial layer.
Most commonly used coating materials include antibiotics, chlorhexidine, chitosan and the derives,
antimicrobial peptides, and materials that can release copper and silver ions (See Table 1). The
bactericidal substances are loaded into the bulk materials via covalent bonding, charging force, or
forming a complex. These coatings kill bacterial cells either via direct contacting or by releasing
antimicrobial agents to surroundings.
An alternative strategy to modification antimicrobials surface for killing is preventing attachment
of cells or disturbing biofilm formation by altering chemical and physical properties of the surface.
Biofilm formation can be prevented by changing the topography, charge, hydrophobicity,
roughness, or stiffness of the materials 15, 72, 73.
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Table 1. Examples of antimicrobial coating and biomaterials
Coating substance
Chlorhexidine
Benzalkonium
chloride
Antimicrobial
peptide

Surface material
Titanium
Polyurethane

Target bacterial species
S. aureus
S. epidermidis

Reference

Hydroxyapatite

64

Antimicrobial
peptides
Chitosan
Chitosan

Hydrogel

S. aureus
P. aeruginosa
S. epidermidis
S. aureus
E. coli
S. aureus

66

S. aureus
S. epidermidis
S. aureus
S. aureus
E. coli
S. aureus
Enterococcus faecalis
P. aeruginosa

67

Copper and fluorine
Silver

Titanium alloy
Collagen
hydrogel
Polyester
Hydroxyapatite

Chlorhexidine

CHG gel

Trimethylammonium Silicone
chloride
S-nitrosothiol
Xerogel

62
63

65

60

68

69

70

71

Most bacterial cells have a negative charge on the outer membrane. Thus, a surface with a positive
charge is more attractive for bacterial cells than the negative charge that can repulse bacterial cells
from attachment 15. Based on this principle, many coating materials have been developed to modify
the surface charge of biomaterials to prevent biofilm formation. For example, polyethylene (PE)
surfaces were modified with a large of negatively charged sodium sulfite using glycidyl
methacrylate (GMA) as the linking agent, which reduces E. coli cell density by 10 times compared
to positively charged surface

74

. Similarly, Carmona-Ribeiro et al.

75

reported that the cationic

antimicrobial substances such as dioctadecyldimethylammonium bromide (DODAB), could
reduce the viability of E. coli, P. aeruginosa, S. aureus as well as C. albicans. However, the
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antimicrobial and antifouling properties of surface charge could be hindered by dead cells, which
cover/neutralize the charges and provide protection to later colonies.
Hydrophobicity is another important factor influencing the antifouling property of biomaterials. In
general, a hydrophilic surface could provide high affinity to water and tissue cells but is also prone
to attachment of bacterial cells. However, the superhydrophilic surface is non-fouling due to the
strong dipoles of the zwitterions and electrostatic interactions

76

.

Making some materials

hydrophobic or superhydrophobic was also found to affect biofilm formation. For instance,
Tripathy et al.

77

showed the coating of copper hydroxide nanowires on polydimethylsiloxane

(PDMS) could reduce the cell density of E. coli up to 5 logs compared to the uncoated surface.
Loo et al. 78 also found the reduced attached P. aeruginosa cells on the polyvinyl chloride (PVC)
surface with the micron-sized particulates and porous structures made by ethanol (35% (v/v) )
treatment. In contrast to typical gram-negative strains, some gram-positive strains demonstrated a
lower affinity to hydrophilic surfaces than hydrophobic ones because of their different surface
proteins 79. Streptococcus mutans biofilms were reduced by 8 times on the surface of resin blended
with

2,2-bis[4-(2-hydroxy-3-methacryloylpropoxy)]-phenyl

propane

(bisGMA),

bis[2-

(methacryloyloxy)ethyl]phosphate (BisMP) and 2-hydroxyethyl methacrylate (HEMA) than
hydrophobic resin. S. epidermis biofilm formation was also reduced on the hydrophilic Pluronic
F127 coated polystyrene surfaces 80.
Surface topography is another feature that attracted much attention, and the specific topographic
patterns can control bacterial cell attachment and biofilm formation. Gu et al.

79

reported the

hexagon-shaped topographic patterns with 15 μm side length, 10 μm height and 2 μm inter-pattern
distance could reduce 85% of biofilm formation and 46% of associated conjugation than a smooth
surface. They also found that the topographic pattern could affect interfere cells cluster formation
15

81

. Manabe et al.

82

demonstrated the porous polystyrene surface could prevent P. aeruginosa

attachment when the pore size was 5 to 11 µm although the pores out of this range promoted cells’
attachment. Xu et al. 83 reported that the adhesion of S. epidermis cells on the polyurethane urea
surface was reduced by micro- and nano-size pillar patterns on the surface. The nano-size patterns
not only reduced bacterial adhesion but also exhibited biocidal effects. Yi et al.

56

reported the

significant killing of bacteria and fungi using the ZnO nanopillar coated surfaces that was inspired
by dragonfly wings.
Although stiffness is an important material property, the effects of stiffness on biofilm formation
have not been systematically studied until recently. Song et al. 15, 84, 85 reported that the attachment
of E. coli and P. aeruginosa was 1 – 2 logs lower on the stiff (5:1) PMDS surface than soft (40:1)
in early biofilm (5h). Besides attachment, bacterial motility was also found differences between
stiff and soft surfaces, which suggests that these cells preferred to settle down on soft PDMS

85

.

However, the antifouling effect of surface stiffness seems also to be affected by material types.
For example, Kolewe et al.

86

found softer hydrophilic PEGDMA and agar hydrogels had less

attached E. coli and S. aureus cells.
2.5 Limitation of present antifouling and antimicrobial approaches
Although many materials have been demonstrated for antimicrobial/antifouling activities during
the last decades, most of these techniques still have drawbacks that limit applications in vivo. For
example, some new bactericidal materials can eradicate pathogens efficiently by direct-contact or
releasing biocidal agents into surroundings, but those materials could also induce the drug-resistant
species during the treatment 87, 88. Furthermore, a few studies reported the cytotoxicity of surfacecoated antimicrobial peptides 89, 90 and silver nanoparticles (Ag-NPs) 91-93 in mammalian cells. The
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antifouling materials with alternated surface chargers, hydrophobicity, topography or stiffness may
be limited to the effect on early biofilm formation, and less effective against later colonizer. Also,
the effects are not complete eradication. Once a few cells have attached and established early
biofilm colonies, they will overcome the antifouling effects over time

15, 85

. Thus, it is important

to develop new techniques that not only have long-term antimicrobial/antifouling effects to present
biofilm formation but also can eradicate existing biofilms. This is of particular importance to
medical device-associated biofilm infections because all the patients have established biofilms.
2.6 Electrochemical control of biofilm
Bacterial control by electrochemical approaches has been explored as an alternative strategy. An
early approach to electric sterilization approach is utilizing high energy electric pulse, also called
pulsed electric field (PEF), to eradicate the microorganisms in a liquid 94. PEF was also found to
inactivate yeast cells in 1980s

95

. Since PEF is a nonthermal process, it has been applied in the

food industry to achieve decontamination of liquid or semi-liquid products, such as milk, juice and
beverages 96-98. The process of PEF shows little effects on proteins, so it could also be applied to
biological products like porcine plasma

99

. The potential of the external electric field for PEF

treatment ranges from volts to kilovolts 98, 100. The killing mechanism of PEF is believed to changes
in membrane permeability and integrity leading to cell lysis 101. When a microbial cell is in a strong
electric field, it could induce a transmembrane potential that is proportional to the external electric
field strength. The cell membrane could break once the transmembrane is over critical value (1V)
102

. If the change is applied for a fairly short time, the cell membrane may still return to normal

state (still weaker than normal cell) when the external electric field is removed, which is a wellknown process of electroporation. However, if the strength and duration of electric field exceed
the critical values, the cell membrane would incur permanent damages that lead to the lysis of the
17

cell

94, 101

. Recently, Pillet

103

reported that PEF also led to cell wall deterioration, such as

decreasing stiffness and hydrophobicity. According to the technique specifications, PEF is not
suitable for applying in human body directly because of its high energy that exceeds the safety
limit.
In 1915, Beattie

104

reported the use of alternating current (AC) to control bacterial cells. It was

found that biocidal effects of AC can be obtained when a very high potential (3000 – 4000 V) was
applied to sterilize milk. In 1962, Brandt et al. 105, 106 first proposed that the free radicals generated
during electric treatment contribute to the killing of bacteria. Rosenberg 107 reported that E. coli
could be killed with 2 A of AC using platinum electrodes. Low-level AC was also found to have
bactericidal effects. Pareilleux et al.

105

reported that the viability of E. coli was reduced after

treatment with 10 to 200 mA of AC in 10s, using stainless-steel electrodes.
Compared to AC, direct current (DC) has received more attention as an alternative antimicrobial
method recently. Rowley

108

first showed the biocidal effects on E. coil with 1- 140 mA DC

conducted with platinum electrodes in 1970s. Baranco

109

demonstrated the killing of S. aureus

cells using 400 µA DC delivered with silver, platinum, gold or stainless steel electrodes. In general,
DC requires lower current levels for bacteria-killing compared to AC. Table 2 shows the
representative examples of studies on controlling bacteria cells using electric current. Most of these
researches used metal electrodes because of their high conductivity, stable electrochemical
properties (e.g. platinum, titanium, gold)

110, 111

, application in medical device (e.g. titanium,

stainless steel) 112, 113, and antimicrobial effects (e.g. copper, silver). The carbon materials recently
become attractive in the researches due to its good corrosion resistance
115

114

and biocompatibility

. Both metal and carbon electrodes show potent bactericidal effects in DC treatment on

pathogenic cells, such as P. aeruginosa, S. aureus, S. epidermidis, and E. coli, although their
18

electrochemical products could be different

116, 117

. The reported reduction effects of electric

current on bacterial cells varied in different experimental conditions (current level, treatment
duration and position of samples). In general, the longer treatment duration could kill more
bacterial cells than short treatment

118-120

, and the biofilm on the electrode surface was more

vulnerable to DC treatment than biofilm away from the electrodes 116, 117, 121, 122. Although a higher
level of electric current absolutely has stronger bactericidal efficacy 118, the recent researches focus
on controlling biofilm with a lower level of DC (1-500 µA) because of the safety issues 116, 117, 120125

.

It is exciting that bacterial killing by DC/AC can be enhanced through synergistic effects with
antibiotics. For example, 2 additional logs of killing of E. coli effects by gentamicin and
oxytetracycline were obtained with concurrent treatment with 6 mA/cm2 of DC

126

. Similar

synergistic effects were also found for AC although the current level of AC was up to 150 mA 126.
In 1994, Costerton et al.

30

also reported that low-level DC could also promote the killing of

antibiotics against bacterial biofilms using P. aeruginosa as the model species.
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Table 2. The examples of researches used electric current to eradicate bacteria cells.
Current/Voltage
Level
3000 – 4000 V

AC/DC

2A
10 - 200 mA
1 - 140 mA
40 and 400 μA

AC
AC
DC
DC

5 – 10 μA
0.7-1.8 mA/cm2

DC
DC

Platinum wire
Stainless steel
Platinum wire
Silver, platinum,
gold, stainless steel
wires
Silver wires
Platinum wires

50 µA

DC

Platinum wires

60 - 100 μA

DC

Stainless-steel

AC

Electrodes
material
Copper

Bacterial Species

Findings

Ref

Mixed species in
milk
E. coli
E. coli
E. coli
S. aureus

Bactericidal effect

104

Division inhibition
Bactericidal effect
Growth inhibition
Bactericidal effect

107

Mixed Oral bacteria
S. epidermidis
P. aeruginosa
K. pneumoniae
P. fluorescens
P. aeruginosa
S epidermidis

Growth inhibition
6-7 logs reduction

127

74% reduction to biofilm
via anodic current

123

76% reduction to biofilm

124

105
108
109

128

125

20-2000 μA

DC

P. aeruginosa
S. aureus
S. epidermidis

3.5 – 5 logs reduction in 27 days treatment
3 logs reduction in 24 h
treatment

118

DC

Stainless steel or
graphite
stainless steel

200 μA
1 – 5 mA

DC

Stainless steel

E. coli and S. aureus

130

2 - 2000µA

DC

100 - 500 μA

DC

Stainless steel,
graphite, titanium
or platinum
platinum

800 mV

DC

Gold

S. aureus,
P. aeruginosa
S. epidermidis
S. aureus
S. epidermidis
P. aeruginosa
E. coli
Candia species
E. coli, S. aureus

5 logs reduction in 40 min
treatment
0.2 – 4.8 logs reduction to
biofilm in 4-7 days
treatment
1.5 – 3 logs reduction to
biofilm in 24 h treatment.
3 – 5 logs reduction to
biofilm in 4 days treatment.

131

−1.8 V for cathode

DC

Titanium

S. aureus

0.5 – 1 logs reduction in 24
h treatment
97% reduction in vitro
98% reduction in vivo
Bactericidal effect
4-7 logs reduction to
biofilm
32 - 67% reduction
7.8 logs reduction to
biofilm with antibiotics
2-7 logs reduction to
persister cells

1.25 – 2V/cm
10 mA

DC/AC
DC

stainless steel
Titanium

E. coli
Anaerobic species

1.5 V
-0.6V

DC
DC

Carbon nanotube
Carbon fabric

E. coli
P. aeruginosa

70 µA/cm2

DC

Stainless
steel/Graphite

P. aeruginosa

129

119

120

132,
133
134
135

136
137

116,
117,
121

2

30 µA/cm

DC

Stainless steel

S. mutans and S.
aureus
20

4-5 logs reduction to
biofilm with antimicrobial

122

2.7 Killing mechanisms of DC
The exact killing mechanism of electric current is still unclear though there are many proposed
theories. For the treatment with high voltage (kV) level electric pulses, the permanent damage of
the cell membranes was observed

101

. In comparison, the effects of low-level DC are thought to

occur via electrochemical products, rather than directly affecting cell membrane integrity. There
are many possible redox reactions that happen at the interface between electrode and electrolyte
solution during electrolysis procedure:
Oxidation reactions on the anode 138:
2𝐻2 𝑂 → 4𝐻 + + 𝑂2 + 2𝑒 −
𝐹𝑒 → 𝐹𝑒 2+ + 2𝑒 −
𝐹𝑒 2+ → 𝐹𝑒 3+ + 𝑒 −
𝐶𝑟 → 𝐶𝑟 3+ + 3𝑒 − (Trace in steel anode)
2𝐶𝑙 − → 𝐶𝑙2 + 2𝑒 −
𝐶𝑙 − + 𝐻2 𝑂 → 𝐻𝐶𝑙𝑂 + 2𝑒 − + 𝐻 +
𝐶𝑙2 + 2𝐻2 𝑂 → 2𝐻𝐶𝑙𝑂 + 2𝑒 − + 2𝐻 +
Reduction reactions on the cathode:
𝐻2 𝑂 + 2𝑒 − → 𝐻2 + 2𝑂𝐻 −
𝑂2 + 2𝐻 + + 2𝑒 − → 𝐻2 𝑂2
𝑂2 + 𝐻2 𝑂 + 𝑒 − → 𝐻𝑂2 ∙ +𝑂𝐻 −
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𝑂2 + 2𝐻2 𝑂 + 2𝑒 − → 𝐻2 𝑂2 + 2𝑂𝐻 −
Redox reactions in the electrolyte solution 139:
𝐹𝑒 2+ + 𝐻2 𝑂2 → 𝐹𝑒 3+ + 𝑂𝐻 ∙ +𝑂𝐻 −
𝐹𝑒 3+ + 𝐻2 𝑂2 → 𝐹𝑒 2+ + 𝑂𝑂𝐻 ∙ +𝐻 +
2𝐹𝑒 3+ + 2𝐻2 𝑂 → 2𝐹𝑒 2+ + 𝐻2 𝑂2 + 2𝐻 +
During DC treatments, the anode material, especially silver, copper or steel, is oxidized and metal
ions (Ag+, Cu2+/Cu+, Cr3+, Fe2+/Fe3+, et al.) are released

121

. These ions could accumulate and

become toxic to bacterial cells by interrupting cells’ and metabolic activities. Moreover, the
generated metal ions could move under an electric field, which can disrupt the integrity of cell
membrane 116, 121. Based on the principles of electrochemistry, reactive oxygen species (ROS) and
free radicals are also generated from the redox reaction involving electrodes. However, this is
difficult to prove directly since many of these species react quickly and thus only have the transient
presence. Hydrogen peroxide (H2O2) is one of several proofed ROS generated in electric treatment.
H2O2 affects the structure and permeability of the cell membrane

140

. The concentration of H2O2

closed to electrode surface ranges from 1ppm to more than 15ppm depending on the current density
141

. However, the concentration decreases quickly over the distance away from the electrode

141

.

Another reported ROS generated during DC treatment is hypochlorite if the electrolyte solution
contains chloride ions. The chloride ions are oxidized on the anode to produce chlorine and
hypochlorite

135

. Hypochlorite could disrupt a series of metabolic activities of bacteria, such as

oxidative phosphorylation and sulfhydration, as well as DNA synthesis

142

hypochlorite depends on the current level and concentration of chloride 135.

22

. The generation of

The mechanism of synergy between antibiotics and electric current treatment is of research interest.
It is speculated that DC weakens the cell membrane leading to higher permeability to antibiotic
molecules 30. Electrochemical products could also disrupt extracellular matrix, and expose biofilm
cells more to antibiotics molecules

143

. Many antibiotics have charges after dissolved, and these

cationic or anionic antibiotic molecules have better penetration to the cell membrane in the
presence of electric field 144. Moreover, some anionic molecules could interact with metal ions to
form a complex that has a higher affinity to cellular targets, such as RNA 145.
2.8 Limitation of conventional DC treatment
An essential requirement for DC treatment with the conventional setup is that the treatment facility
(electrodes) must be connected to a power source by wires. This limits the in vivo applications,
especially for treatment in deeper tissues. To deliver electric current, the electric wires must be
introduced into the body to reach the treatment site. There are two options to achieve this: 1) insert
wires through natural pores (oral, nasal, ear canal, etc.) if the treatment site is in the mouth, nose
or ear. 2) pierce skin directly to insert wire from outside to the treatment position. Both options
would bring discomfort to the patient. Moreover, skin-piercing increases the risk of secondary
infection 146, since the piercing breaks the skin barrier. The wiring requirement needs to be solved
if we want to apply electric current for human therapy. This motivated us to develop a platform to
deliver DC wirelessly for bacterial control.
2.9 Wireless charging technologies
Wireless charging (also known as inductive charging) is a technique that uses an electromagnetic
field to transfer electric energy between two objects. The transfer medium is radio wave, and the
phenomena are called resonant inductive coupling between two conducts. In 1894, Nikola Tesla
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first used this principle to light up a phosphorescent and incandescent lamp without direct
connection with a power cord

147

. The early devices of wireless electric delivery needed a very

high voltage at high frequency (~150 kHz) in the 19th century. In 1960s, the first wireless electric
delivery system was developed for the pacemaker, and the distance of wireless delivering was less
than 20 cm 148.
Recent research on wireless electric delivery can be divided into three major fields. One focuses
on improving charge efficiency (up to 75 – 80%) and the other on developing rapid charging at
kilowatt power levels for those high-power electric consumers, such as road electrification devices.
The third field is working on low milliwatt power levels that could provide stable and safe electric
power to implantable and wearable devices 148.
Today many types of medical devices carry a wireless electric delivery system, such as pacemaker,
cochlear and gastric stimulation implants 149 150, 151. The major advantages of wireless charging for
medical implants include low risk of infection and good reliability. Since the magnetic field could
penetrate the skin tissue and pass the energy to the device in vivo, there is no requirement for skin
piecing, which could reduce the risk of post-surgical infection. Wireless charging device also
avoids the use of batteries, which need replacement, and are associated with the issues of corrosion.
To achieve wireless electric delivery by resonant inductive coupling, it requires two basic subsystems are required: a transmitter unit and a receiver unit. The transmitter unit is composed with
a transmitter coil (primary coil) and controller chips. The transmitter coil can transfer alternating
current to a time-changing magnetic field because the conduct with electric current could generate
a magnetic field on the surrounding. The controller chips are used for adjusting the frequency and
current level of AC in the coil to obtain the desired strength and frequency of the magnetic field.
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The magnetic field can use radio wave to transport and penetrate the barrier, so no wire or other
physical medium is required. The receiver unit is composed of a magnetic coil and another
controller chips. The magnetic coil works as an antenna to receive the magnetic field and then
transfers back to altering current according to the Faraday's law of induction. The function of
controller chips in receiver unit is to convert AC to a stable DC. This DC level can be adjusted
from µA to mA level for effective control bacterial biofilms.
2.10 Materials and methods used in research
2.10.1 Strains
Wild-type Staphylococcus aureus and Pseudomonas aeruginosa PAO1 strains were chosen as
representative species in this study. S. aureus is a gram-positive strain and commonly found in the
human bodies, such as nose, respiratory tract, and skin. It is also an important pathogen that causes
community and hospital-acquired infections. There have been almost 500,000 cases of S. aureus
infections reported in U.S. and 58% of these are related to Methicillin-resistant S. aureus (MRSA)
strains

152

. For implant-associated infections, the prevalence of S. aureus is 35.5% in orthopedic

implant infection cases based on an epidemiology study 153. P. aeruginosa is a gram-negative strain
and one of the most significant pathogens. Since P. aeruginosa can form robust biofilms on the
surface of biomaterials, it is commonly linked to chronic infections after implant surgery

53

.

According to the CDC, there are about 51,000 healthcare-associated P. aeruginosa infections
annually in the U.S., causing approximately 400 deaths.
NCI-H1299 (ATCC® CRL-5803™) human epithelial cells and C3H/10T1/2, Clone 8 (ATCC®
CCL-226™) mice fibroblast cells are chosen as mammalian cells to investigate the effect of
wireless DC treatment on mammalian cell lines. We used these mammalian cells to mimic the host
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tissue cells around implant sites to evaluate the cytotoxicity of wirelessly delivered DC. The cells
are grown on the bottoms of mammalian culture petri dishes and treated under the same conditions
as bacteria cells.
2.10.2 Substrate material for biofilm formation
Poly(dimethylsiloxane) (PDMS) is chosen as the substratum material for biofilm growth in this
study. This material is broadly used in medical devices, especially as biocompatible case material
for electronic implant devices (such as cochlear implants, pacemakers, GI track stimulators, et al.)
154, 155

. According to the previous researches, the silicone shells are the primary sites for biofilm

formation since this material is susceptible to bacterial attachment 38. Hence, the biofilm formed
on PDMS surface is a suitable infection model for our research.
2.10.3 Wireless charging system
The electromagnetic field used in this research is the extremely low field (ELF) with a frequency
of 100,000 Hz. The in vitro system of wireless DC delivery was connected to a treatment facility
(petri dish with two electrodes) in the series circuit. It contained an AC power source, transmitter
coil & controller chip, receiver coil & controller chip, and an external resistor (Figure 1). The
transmitter and receiver coils were used to achieve wireless electric delivery by coupling induction.
The main functions of the controller chip are AC/DC conversion as well as controlling the
frequency of the electromagnetic field. An external resistor was used to adjust DC level in the
treatment circuit. A multimeter was included into the circuit during setup to monitor the voltage
across the external resistor. The current level was calculated based on below equation:

𝐼𝑡𝑜𝑡𝑎𝑙 =

𝑈 𝑟𝑒𝑠𝑖𝑠𝑡𝑜𝑟
𝑅𝑟𝑒𝑠𝑖𝑠𝑡𝑜𝑟
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Figure 1. The actual circuit of wireless DC delivery system in our research (1: Treatment petri
dish. 2: Adjustable resistor. 3: Fixed resistor. 4: transmitter and receiver coils. 5: Multimeter.)

2.10.4 Cytotoxicity test
To evaluate the safety of DC to human tissue, it is essential to test cytotoxicity to mammalian cell
lines after the treatment with wirelessly delivered DC. In this study, we used Live/Dead staining
to differentiate health cells and dead injured cells after treatment. This Live/Dead staining is based
on the difference in membrane permeability between live and dead cells, and thus the labeling
efficiency between green (live cells) or red (dead cells) fluorescence. The staining kit contains two
different dyes: Calcein AM and Ethidium homodimer-1. Calcein AM has green fluorescence with
ex/em wavelength of 494/517 nm, while Ethidium homodimer-1 has red fluorescence with ex/em
wavelength of 528/617 nm. The Calcein AM is polyanionic and retains on live cells membrane.
The Ethidium homodimer-1 can only penetrate the damaged membrane of dead or unhealthy cells
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and bind to nucleic acid. Once binding to DNA, Ethidium homodimer-1 has 40-fold enhancement
of fluorescence, so that the dead cells would have a bright red color under fluorescence microscopy.
The membrane of intact cell blocks the penetration of Ethidium homodimer-1 so that they have a
green color under fluorescence microscopy.
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Chapter 3
The proof-of-concept study of wirelessly delivered DC treatment on
biofilm cells
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3.1 Abstract
Bacteria such as Pseudomonas aeruginosa and Staphylococcus aureus can form biofilms on
medical implants and cause serious infections that are incurable by conventional antibiotics due to
high-level tolerance to antimicrobials. In this study, we developed a new method towards the noninvasive treatment of biofilm infections. We demonstrate that antibiotic tolerant biofilm cells can
be effectively eradicated by electromagnetically induced direct current (DC) from a remote power
source. For example, after treatment with 60 µA/cm2 of wirelessly delivered DC using stainless
steel electrodes for 6 hours, the viability of Pseudomonas aeruginosa and Staphylococcus aureus
biofilm cells was reduced by approximately 3.4 and 2 logs, respectively. DC generated with
graphite-based TGONTM electrodes was also effective especially against S. aureus. For example,
the viability of P. aeruginosa and S. aureus biofilm was reduced by 1.4 and 2.5 logs, respectively,
after treatment with the 30 µA/cm2 of wirelessly delivered DC for 3 hours. Synergy in biofilm
killing was also observed between lower level DC and antibiotics. The viability of P. aeruginosa
biofilm was reduced by 1.6 logs after concurrent treatment with 12 µA/cm2 wireless delivered DC
and 4.5 µg/ml tobramycin. In comparison, treatment with the same level of DC or tobramycin
alone only showed 0.8 and 0.5 log of killing, respectively. The viability of S. aureus biofilm was
reduced by 2.2 logs after concurrent treatment with 6 µA/cm2 DC and 10 µg/mL chlorhexidine,
while treatment with the same level of DC or chlorhexidine alone only showed 1.1 logs and 0.6
logs of killing, respectively. These conditions were found safe to the human epithelial cell line
CLR 5803 and mice fibroblast cell line C3H/10T1/2, Clone 8.
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3.2 Introduction
Application of surgically implanted medical devices is on the rise, thanks to the advances in device
design and major benefits to patients’ life quality 1. However, device-associated infections remain
challenging despite the improvement on sterilization techniques over the past decades 2.
Approximately 4.3% of the total 2.6 million orthopedic devices implanted in the United States
every year are infected 3. The risk of infections associated with hearing aid implants (e.g. cochlear
and bone anchored implants) is also approximately 4 % but higher among younger patients

4, 5

.

Such infections lead to ulcer, swelling or inflammation of affected tissues 6, and in some cases,
additional surgeries for implant relocation, fixation or even explanation 7. In severe cases, deviceassociated infections can lead to life-threatening conditions such as meningitis 6, 8-10.
It is well documented that bacterial biofilms play an important role in recalcitrant implantassociated infections 7. The source of these bacteria is commonly linked to the ambient
environment, surgical equipment, or the patient’s own skin 11. The concept of “race for the surface”
well describes the nature of device-associated infections; e.g., if bacterial adhesion occurs on
implanted biomaterial before tissue integration, it is difficult to prevent further biofilm formation
by host defense 12. However, infections can also occur years after the operation

13, 14

. The major

causative agents of implant-associated infections include Staphylococcus aureus, Staphylococcus
epidermidis, Pseudomonas aeruginosa and Streptococcus species 6, 14-18. Gram-positive S. aureus
and Gram-negative P. aeruginosa are the most commonly isolated strains from infected implanted
devices 6, 14, 17.
A common strategy for controlling device-associated infection is coating with antimicrobials that
are either released from the implant surface 19, 20 or immobilized on the surface 21. Besides, biofilm
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formation can be reduced by chemical and physical modification of material properties, such as
charges, hydrophobicity, topography and stiffness

22-24

. Although these approaches can

reduce/delay biofilm formation, many of these mechanisms can be overcome by bacteria over time,
and eradicating mature biofilms remains challenges. Direct currents (DCs) have been shown to
have bactericidal effects against established biofilm cells; and synergy between DC and antibiotics
in bacterial killing has been observed in multiple systems including in vivo models 25-32. However,
these systems require a direct connection between electrodes and a power source, which requires
skin-piercing wiring for current transduction. This is an invasive process, which causes discomfort
and can lead to secondary infections. These limiting its application in the treatment of device
associated infections.
To improve infection control by DC, we developed a method to induce DC wirelessly using a
magnetic field. P. aeruginosa and S. aureus were used as model species in this study to test this
new strategy. The results demonstrate that wirelessly delivered DC has strong effects in killing
planktonic and biofilm cells of P. aeruginosa and S. aureus, and the treatment conditions are safe
to human epithelial cells.

3.3 Materials and methods
3.3.1 Bacteria strains and growth media
P. aeruginosa PAO1 and S. aureus ALC2085 (strain RN6390 containing pALC2084) were
routinely cultured in Luria-Bertani (LB) medium 33 containing 10 g/L tryptone, 5 g/L Yeast extract
and 10 g/L NaCl at 37 °C with shaking at 200 rpm. Chloramphenicol was supplied at 10 μg/mL
for S. aureus cultures.
50

3.3.2 Biofilm formation
Polydimethylsiloxane (PDMS) blocks (1 cm x 0.5 cm; 0.1 cm thick) were used to form biofilms
because it is a commonly used biomaterial for medical devices, such as cochlear implants and
pacemakers 34, 35. Briefly, 25 µL overnight culture of planktonic cells was used to inoculate a petri
dish containing 25 mL of LB medium and PDMS blocks. The biofilm cultures were incubated at
37°C for 24 h without shaking. After biofilm growth, the PDMS blocks with attached biofilms
were removed from the petri dish and washed gently with 0.85% NaCl solution prior to DC
treatment.
3.3.3 Wirelessly delivered DC treatment
The setup of the experimental system for wirelessly delivered DC generation is shown in Figure
1. Briefly, the treatment circuit was constructed with two stainless steel (McMaster-Carr, Elmhurst,
IL, U.S.) or TGON™ 805 (Laird Technologies, Schaumburg, IL, U.S.) electrodes positioned on
the opposite sides of a 35 mm petri dish (Thermo Fisher Scientific, Pittsburg, PA, U.S.). To deliver
DC wirelessly, the electrodes were connected to a rectifier (XKT-3168, Xinketai, China) and then
to a copper receiver coil (10 turns, 5 cm diameter, 0.7 mm thickness) (McMaster-Carr, Elmhurst,
IL, U.S.). The total current level of treatment circuit was controlled using adjustable resistors (10
k – 10 M ohm). The receiver coil was placed on a phone wireless charging pad (Yootech, T100,
JinJiang, China) or a wireless charging module (XKT-412, Xinketai, China) as a power source.
Electric power was delivered wirelessly based on the principle of coupling induction between the
transmitter coil and receiver coil. The electric power consumption of DC treatment can be
calculated using the Equation 1 36:

𝑃𝑜𝑤𝑒𝑟 =

(𝑈𝑡𝑜𝑡𝑎𝑙 −𝑈𝑅 )2
𝑅

(1)
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Where Utotal is the total potential output of rectifier chip (5V in our system), UR is the average
potential applied on the adjustable resistors, and R is resistance value of resistors. All of them were
monitored by using a multimeter (Metex, M4640A, Toronto, ON, Canada).
To understand if the presence of skin tissue may affect wireless DC delivery, a porcine skin
purchased from a local grocery store was inserted between transmitter and receiver coils, and the
current density in the internal circuit was monitored in the same method.
3.3.4 DC treatment of biofilms
DC treatment of biofilms was carried out in 3 mL 0.85% NaCl solution. The PDMS blocks with
attached P. aeruginosa PAO1 or S. aureus ALC2085 biofilm were placed in the middle of the
electric field with approximately 2-3 mm from each electrode. The biofilm was treated with DC
for 2-6 hours. The untreated samples were used as controls. After treatment, each PDMS block
was transferred to a 10 mL tube containing 1 mL 0.85% NaCl solution. The biofilm cells were
removed from the surface by gentle sonication (Model B200, Branson, Danbury, CT, USA) for 1
min. The number of viable cells detached from PDMS blocks was quantified by counting CFU.
Tobramycin (Tob) and chlorhexidine (CHX) were used to evaluate possible synergy with lowlevel DC in bacterial killing. PDMS blocks with P. aeruginosa PAO1 biofilm were concurrently
treated with 12 µA/cm2 DC and 4.5 µg/mL Tob for 6 h and compared with individual treatment.
PDMS blocks with S. aureus biofilm were concurrently treated with 6 µA/cm2 DC and 10 µg/mL
CHX for 6 h and compared with individual treatments. The number of viable biofilm cells was
quantified by counting CFU.
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3.3.5 Scanning Electron Microscopy (SEM)
SEM was performed to evaluate the effects of the wireless electrochemical treatments on P.
aeruginosa and S. aureus biofilm cells compared to the untreated control. The treated and control
PDMS with biofilm samples were gently rinsed with PBS and fixed with 2.5% glutaraldehyde in
1X PBS buffer (pH 7.4) for 3 days at 5 °C. Then the samples were fixed in 2.0% osmium tetroxide
(MilliporeSigma, St. Louis, MO, US) for 1 h, and washed by DI water again followed by
dehydration in a graded ethanol series (15%, 30%, 50%, 70%, 90%, and 100%). The final
dehydration in 100% ethanol was repeated three times. After dehydration, the samples were critical
point dried with 100% ethanol in a Tousimis samdri-810 (Tousimis, Rockville, MD). Finally, the
samples were coated with approximately a 5 nm gold and imaged using a Scanning Electron
Microscope (JEOL 5600, JEOL, Japan) at an accelerating voltage of 7 kV.
3.3.6 Cytotoxicity to human cells
Human epithelial lung cancer cell line (CLR-5803) was grown in 35 mm glass bottom petri dish
(Thermo Fisher Scientific, Pittsburg, PA, U.S.), with RPMI 1640 medium supplemented with 10%
Fetal Bovine Serum (FBS) (Thermo Fisher Scientific, Pittsburg, PA, U.S.)

37, 38

for 2 days. Mice

fibroblast cell line (C3H/10T1/2) was grown in the same petri dish with Eagle's Basal
medium supplemented with 10% Fetal Bovine Serum (FBS) and 2mM L-glutamine 39, 40 (Thermo
Fisher Scientific, Pittsburg, PA, U.S.) for 2 days. Then two electrodes (stainless or TGON) were
inserted into the petri dish to deliver 30 - 60 µA/cm2 wirelessly induced DC at 37 °C supplemented
with 5% CO2. After DC treatment, the mammalian cells on the bottom of petri dish were stained
using the Cell-Mediated Cytotoxicity Kit (Life Technologies, Grand Island, NY, USA) 30 min,
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followed by observation with a fluorescence microscope (Axio Imager M1, Carl Zeiss Inc., Berlin,
Germany) to evaluate viability.
3.3.7 Statistical analysis
All data are presented as a mean ± standard deviation. Statistical significance was assessed with
one-way or two-way ANOVA followed by Tukey test. Results with p < 0.05 were considered
statistically signiﬁcant. All analyses were performed using SAS 9.4 software (SAS Institute, Cary,
NC, USA).

3.4 Results
3.4.1 Engineering a new system for wireless delivery of DC at therapeutic levels
Our design is based on the principle of induction coupling. The system we developed for wireless
DC delivery included an AC power, a pair of transmitter and receiver coils, and a rectifier chip
connected to the biofilm treatment unit. In the first test, the system was evaluated in a petri dish
with two electrodes (Figure 1A&B). The AC power and transmitter coil composed the power
transmitter unit; while the receiver coil, rectifier chip and an adjustable resistor composed DC
generation unit. Using this setup, the electric power was transferred to a time-changing magnetic
field by the transmitter unit first and then transferred back to electric current in the receiver unit
by induction coupling. The AC current was transformed to stable DC by the rectifier and delivered
to the treatment unit (Figure 1B). Although a larger receiver coil could provide higher efficiency
of coupling induction, we chose the coil with 3 cm of diameter in this study (Figure S3), because
it is close to the diameter of typical electric medical implants, such as pacemaker, cochlear implant,
and GI tract stimulator 38, 41, 42.
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The current densities of our wireless DC delivering system were tested from 6 to 120 µA/cm2,
which was stable during 3 - 6 h treatment. We also measured the current density with varying
distance between the charging pad and receiver coil. The current density remained at the stable
and high level when the distance varied from 0 to 10 mm, beyond which the current density started
to decrease (Figure 1C). When the distance increased to 15 mm, the current density decreased to
approximately 2/3 of the maximum level. This result indicates that the wireless delivery of DC can
penetrate skin and tissues without significant decay (Figure 1C). The maximum power required to
obtain 60 µA/cm2 output current in our experimental system is approximately 0.1 mW based on
the calculation using Equation 1 shown in the Methods section. By enhancing the power output,
the distance for DC delay can be substantially increased if needed.
3.4.2 Effects of DC on P. aeruginosa and S. aureus biofilms using stainless steel electrodes
The maximum killing effect on P. aeruginosa biofilms among the tested conditions was observed
when treated with 60 µA/cm2 DC for 6 h, which was 3.4 ± 0.03 logs (p = 0.03). This killing was
reduced to 2.4 ± 0.17 logs when the DC treatment was shortened to 2 h (Figure 4). At lower current
levels, the 6 h treatment with 6 or 30 µA/cm2 DC killed 0.4 ± 0.04 (p < 0.05) and 1.8 ± 0.001 logs
(p = 0.04), respectively. Thus, biofilm cells are more tolerant to DC treatment as expected. No
significant killing was observed at any of these current levels when the treatment time was
shortened to 2 h (Figure 2A). These results demonstrated the dosage-dependent killing of P.
aeruginosa by wirelessly delivered DC.
Wirelessly delivered DC was also found effective against S. aureus biofilms under the same
treatment conditions. Specifically, the number of viable S. aureus biofilm cells was reduced by 1.6
± 0.02 and 2.2 ± 0.2 logs after treatment with 60 µA/cm2 DC for 2 and 6 h (p < 0.01), respectively.
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DC at 30 µA/cm2 showed similar killing activities against S. aureus biofilms (1.2 ± 0.01 and 1.9
± 0.02 log for 2 and 6 h treatment, respectively; p < 0.01); while 6 µA/cm2 DC only exhibited
significant killing effect (1.1 ± 0.05 log) with 6 h treatment (p < 0.01) (Figure 2B). When current
density increased up to 120 µA/cm2, the number of viable S. aureus cells was reduced by 2.4 ±
0.01 logs for 6 h treatment (p < 0.01).
To better understand the killing effects of wireless electrochemical treatment on biofilm cells,
SEM analysis was performed to examine the morphology of P. aeruginosa and S. aureus biofilm
cells with and without treatment by wirelessly delivered DC. The SEM results revealed major
damage to the treated cells, consistent with the potent killing effects of DC observed. For example,
after treatment with 60 μA/cm2 DC for 6 h, The majority P. aeruginosa and S. aureus cells were
disrupted, and cell debris was seen for treated samples (Figure 3), which is consistent with CFU
results described above.
3.4.3 Synergy between DC and antimicrobials in killing P. aeruginosa and S. aureus biofilms
using stainless steel electrodes
Low-level electric currents are known to have synergy with antibiotics in killing bacterial biofilm
cells

43, 44

. To understand if wirelessly induced DC also has such effects, tobramycin (Tob) was

tested on P. aeruginosa PAO1 biofilms. When P. aeruginosa biofilms were treated with 12
µA/cm2 DC and 4.5 µg/mL tobramycin (Tob) for 6 h, the maximum killing effect (1.6 ± 0.1 logs,
p = 0.003) was observed under the condition of concurrent treatment with both DC and Tob present.
In comparison, treatment with 12 µA/cm2 DC or 4.5 µg/mL Tob alone only showed 0.8 ± 0.3 logs
and 0.5 ± 0.3 log of killing, respectively (Figure 2C). Thus, synergy was observed between
wirelessly delivered DC and Tob.
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Similar to the results of P. aeruginosa, concurrent treatment with wirelessly delivered DC and
chlorhexidine (CHX) was found to have synergetic effects in killing S. aureus biofilms. For
example, the number of viable S. aureus biofilm cells was reduced by 2.2 ± 0.05 logs (p < 0.01)
after concurrent treatment with 6 µA/cm2 DC and 10 µg/mL CHX for 6 h. In comparison, treatment
with 6 µA/cm2 DC or 10 µg/mL CHX alone only showed 1.1 ± 0.05 log and 0.6 ± 0.03 log of
killing, respectively (Figure 2D).
3.4.4 Effects of DC on P. aeruginosa and S. aureus biofilms using TGONTM 805 electrodes
Carbon is a good nonmetal material for medical implants because of its corrosion resistance and
good biocompatibility

2, 45

. Unlike stainless steel, carbon-based electrodes don’t produce salt

precipitation, which helps keep the biomaterial clean after DC treatment 46. To understand if it is
also effective for bacterial killing by wirelessly delivered DC using carbon-based electrodes, we
treated P. aeruginosa and S. aureus biofilms using the same test system but replaced by replacing
stainless steel electrodes with the TGONTM 805. TGON is a graphite-based material that has higher
flexibility and conductivity than normal carbon electrodes
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. The results showed that treatment

with 30 µA/cm2 DC for 3 h led to the killing of P. aeruginosa and S. aureus biofilm cells by 1.8 ±
0.08 (p < 0.01) and 2.9 ± 0.5 logs (p = 0.01) (Figure 2 E&F), respectively. These effects are
compatible to those by stainless electrodes and more potent in killing S. aureus.
3.4.5 The effective DC levels for bacterial killing are safe to human cells
To understand if the conditions effective in bacterial killing are safe to human cells, human lung
epithelial cell line (CLR-5803) was used to evaluate the effects of DC. The microscopic images of
epithelial cells stained with Cell-Mediated Cytotoxicity kit showed no notable difference between
DC treated epithelial cells and untreated control. As shown in Figure 4, nearly all mammalian cells
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remain viable (stained green) after treatment with 60 µA/cm2 DC using stainless steel electrodes
for 6 h or 30 µA/cm2 DC using TGON electrodes for 3 h, which were potent in killing P.
aeruginosa and S. aureus.

3.5 Discussion
Different levels of direct currents (DC) and alternative currents (AC) have been demonstrated to
kill biofilm cells in the presence or absence of antibiotics

28, 31, 32, 43

. Our group recently reported

synergetic effects between low-level DC and the antibiotic tobramycin in killing P. aeruginosa
biofilm and dormant persister cells 29, 30. These data suggest that new treatment may be possible to
better combat antibiotic-resistant infections. However, all those systems require a physical
connection between the electrodes and a power source. Such setup needs skin piecing or battery if
applied to implanted medical devices, which presents challenges such as limited device lifetime,
pain, discomfort associated with the treatment, and risk of secondary infections. To address this
challenge, we generated electric currents wirelessly by induction coupling and achieved effective
killing of bacteria (both planktonic and biofilm cells); and synergy with antibiotics was also
observed. Our results showed that the viability of P. aeruginosa and S. aureus biofilm cells could
be reduced by 3.4 and 2.2 logs, respectively, with 6 h treatment of 60 or 120 µA/cm2 DC conducted
with stainless steel electrodes in saline solution compared to the untreated controls. Extremely low
levels of DC (0.06 – 0.6 µA/cm2) also exhibited a significant killing effect on planktonic cells,
although not biofilms (Supplementary data, Figure S1). Synergetic effect was observed for
concurrent treatment of P. aeruginosa biofilm with 12 µA/cm2 DC and 4.5 µg/mL Tob for 6 h,
which led to 1.8 logs of killing, and the viability of S. aureus biofilm was reduced by 2.2 logs by
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concurrent treatment with 6 µA/cm2 DC and 10 µg/mL CHX for 6 h. Similar killing effect to
biofilm cells was also observed by the treatment with 30 µA/cm2 DC using graphite electrodes
(TGON) for 3 h. Furthermore, the same treatment conditions were found safe to human epithelial
cells.
To our best knowledge, this is the first application of wirelessly induced current for bacterial
control. We believe it has promising in vivo applications because wireless power technology has
been successfully for charging implanted devices in human

47

, such as pacemakers, deep brain

stimulators, and cochlear implants. These systems have two coils located inside and outside of the
human body respectively 48-50. The electric power is delivered by inductive coupling between the
two coils. Electromagnetic inductive coupling could power the implanted devices wirelessly
through the skin and tissues without any skin piercing, indicating the safety of such delivery
methods. Typical power supply for wireless electronic implants is approximately 40 - 80mW 51,
which is much higher than the power requirement for DC treatment under our experimental setup.
Since our effective current level (30 - 120 µA/cm2) is lower than those of wired systems
demonstrated to be safe in vivo 52, 53, we expect that it is practical to integrate DC treatment unit
for treating biofilm infections associated implanted devices. In this study, we demonstrated that
DC can be delivered through a distance of 10 mm, which exceeds the maximum thickness of skin
54

. This indicates the feasibility as some other wireless electronic implants (e.g. pacemaker and

hearing aids) that are usually placed under the dermis tissue

3, 41, 55, 56

. For some devices such as

cochlear implants and pacemakers, it is possible to keep the original wireless charging module and
rewire the system to provide both original charging function and added infection control. It is also
possible to monitor biofilm formation by measuring impedance changes of the implanted device
and apply therapeutic DC on demand. The maximum current density of DC that can be safely
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applied in the human brain is 2 mA/cm2

57-59

. The DC density used in this study is much lower

than that (<120 µA/cm2) and thus is expected to be safe with room to achieve even higher
efficiency in biofilm control. In our study, we reduced the viability of P. aeruginosa planktonic
cells by 2 logs with only 0.06 µA/cm2 DC in 6 h, although the biofilm cells required longer
treatment time or higher DC level (still less than the mA/cm2 level of safe limit 60).
The working distance between the transmitter coil and receiver coil is approximately 10 mm that
is enough for several types of implants, such as implanted hearing aids devices and pacemaker,
which are typically implanted under the skin

3, 38, 41, 55, 56

. If a device is implanted at a deeper

position, e.g. gastrointestinal stimulator, the size of charging coil can be enlarged or amended by
adding a resonant coil to achieve deeper penetration for DC delivery, e.g. 5-15 cm 38, 61.
The coupling induction technology that utilizes a time-varying magnetic field as the carrier is
applicable to implanted medical devices since it can deliver electric power and signals wirelessly
without skin piecing wires 47. The safety limitation for the time-varying magnetic field contains
two parameters: magnetic field strength (Tesla) and frequency (Hz). The magnetic field’s strength
in our experiment is less than 0.02 mT with the frequency of 100-200 kHz, which is much lower
than the magnetic field (0.1 – 2 mT, 200 kHz) applied for healing bone fractures and this expected
to be safe 62. The application in bone nails and other orthopedic devices are more complex but can
be archived by adding a receiver coil and electronic rectifier prior to implantation to generate
desired DC on demand. Many orthopedic devices are implanted in the arms and legs that are far
from the critical nervous system; thus, the applied DC level can be even higher to better
antibacterial effects including that on antibiotic-resistant strains. The DC generation unit can also
be implanted away from the device to minimize the change to devise design. Further in vivo studies
are needed to identify the best treatment condition, e.g., relatively high current and short time or
60

low current but long treatment time given enough room of safe DC level that can be adjusted. This
is part of our ongoing effort.

3.6 Conclusion
In summary, we demonstrated the feasibility to integrate the wireless delivery of DC and
electrochemical control of biofilm cells. DC generated using wireless coupling induction was
found effective in killing the model organisms P. aeruginosa and S. aureus biofilms, and synergy
in bacterial killing was observed between DC and antimicrobials (tobramycin and chlorhexidine).
The killing effect of low-level current was time- and current level-dependent. Wireless delivery of
DC can avoid skin piercing, which eases its future application in non-invasive control of biofilm
infections. The prototype device with the function of wirelessly delivered DC treatment showed
the potent killing of biofilm cells in both in vitro and ex vivo models, which provide a new platform
technology for future device engineering.
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3.9 Figures

Figure 1. Engineered system for wireless delivery of DC. (A) Block diagram of wireless DC
delivery system. Alternating current (AC) is generated by an AC power source, which is
transferred to a changing magnetic field by coil 1. Next, coil 2 receives the magnetic field and
transfers back to AC by induction coupling. The AC is converted to DC by a rectifier, followed by
delivery of DC to the treatment petri dish with electrodes and attached biofilm samples. (B)
Schematic of the DC delivery system including the power transmitter unit, receiver unit, and
treatment unit. (C) The current density of the wireless DC delivery system with varying distance
between the transmitter and receiver coil. The system was able to deliver DC over 10 mm under
our experimental condition, which can be increased by using larger transmitter coil and higher
frequency.
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Figure 2. Viability of bacterial cells after treatment with wirelessly delivered DC in the absence or
presence of antimicrobials. (A)&(B): Viability of P. aeruginosa (A) and S. aureus (B) biofilm
cells after treatment with 6, 30, 60 or 120 µA/cm2 DC in 0.85 % NaCl for 2 or 6 h. (C)&(D):
Viability of P. aeruginosa (C) and S. aureus (D) biofilm cells after treatment with antimicrobials
70

alone (4.5 µg/mL Tob or 10 µg/mL CHX), DC (6 or 12 µA/cm2) alone or concurrent treatment for
6 h in 0.85 % NaCl solution. (E)&(F): Viability of P. aeruginosa (E) and S. aureus (F) biofilm
cells after treatment with 12 or 30 µA/cm2 DC conducted by TGONTM 805 electrodes in 0.85%
NaCl for 3 h.

Figure 3. Representative SEM images of untreated (A) and DC treated (B) P. aeruginosa and S.
aureus biofilms. Wirelessly delivered DC at 60 μA/cm2 was used to treat biofilm cells using
stainless steel electrodes. Bars = 1 μm.
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Figure 4. DC treatment of CLR-5803 epithelial cells and C3H/10T1/2 mice fibroblast cells
attached on the glass bottom petri dishes in RPMI medium supplemented with 10% FBS. (A)&(B):
The epithelial cells were treated without (A) or with (B) 60 µA/cm2 DC conducted by stainless
steel electrodes for 6 h. (E)&(F): The samples were treated without (E) or with 30 µA/cm2 DC (F)
using TGONTM 805 electrodes for 3 h. (C)&(D): The fibroblast cells were treated without (C) or
with (D) 60 µA/cm2 DC conducted by stainless steel electrodes for 6 h. (G)&(H): The samples
were treated without (G) or with 30 µA/cm2 DC (H) using TGONTM 805 electrodes for 3 h. Bar =
50 µm.
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Chapter 4
Designing and engineering a prototype device of wirelessly delivered
DC treatment
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4.1 Abstract
In Chapter 3, we have demonstrated that the wirelessly delivered direct electric current (DC) could
achieve a good killing effect on both P. aeruginosa and S. aureus biofilms. In this Chapter, we
engineered a prototype device to evaluate the feasibility of integrating the system of wirelessly
delivered DC treatment into the implant device. The different device designs with varying shapes,
electrode layouts, and electrode materials were compared based on the results of COMSOL
simulation, and the selected design contained a circular cathode on the vertical side around the
round-shaped device and a small square anode in the center of the device surface. The prototype
device shows the 1.0 log and 2.6 logs killing of P. aeruginosa and S. aureus biofilms, respectively,
with 6 µA/cm2 of wirelessly delivered DC using an ex vivo model with the porcine skin for 6 h
treatment.
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4.2 Introduction
Surgically implanted medical device are widely used due to their benefits in both diagnostic and
therapeutic processes as well as the improvement of patient’s life quality 1. However, the events
of infection associated with implants remain concerning despite the improvement in sterilization
techniques during the last decades 2. For example, approximately 4.3% of the total 2.6 million
implanted orthopedic devices got infection in the United States every year 3. The risk of cochlear
implant (CI)-associated infection is also approximately 4% but higher in younger patients 4. CI is
an electronic device that provides hearing aids to patients with deafness 5. The main components
of CI are housed in a polysilicon case containing antenna coils, receiver/stimulator modulus,
magnet and electrode arrays which connect to the vestibulocochlear nerve system 6 7. The implant
infection can lead to not only ulcer, swelling or inflammation of affected tissue 8, but also further
surgeries for implant relocation, fixation and even explanation 9. In some severe cases, the CIassociated infection can lead to meningitis, a life-threatening condition 8, 10.
Previous studies have shown that bacterial biofilms play an important role in medical implantassociated infections 9, 11, 12. The major causative agents of these infections include Staphylococcus
aureus, Pseudomonas aeruginosa and Streptococcus species 8, 13-15. S. aureus is a common strain
isolated from contaminated devices

8, 14

and commonly cause ulcer and swelling, while P.

aeruginosa can form the robust biofilm on the devices’ surfaces and lead to the chronic and
secondary infections 4. Recently, the Streptococcus species, especially S. pneumonia attract more
attention due to the associated high risk of meningitis among children with CI implants.
Direct currents (DCs) have been shown to have bactericidal effects after either by itself or through
synergy with antibiotics

16-26

. However, these systems all require a direct connection between
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electrodes and power sources, which requires skin-piercing wiring for current transduction if the
treatment site is inside the body 27-29.
In Chapter 3, we developed a system to deliver DC wirelessly using a magnetic field based on
inductive coupling. Several implantable biomedical devices are currently in use with inductive
coupling to achieve wireless communication 30, such as pacemakers, deep brain stimulators, and
cochlear implants, indicating the feasibility of this approach in infection control. Our system
includes two magnetic coils that are similar to the devices mentioned above. The electrical power
is delivered through electromagnetic induction between the two coils, which can power the implant
devices wirelessly through the skin and tissues without any skin-piercing. The DC could perform
electrochemical treatment (with an additional control to obtain the appropriate current level) of
biofilm infections in vivo. However, there are a series of issues that need to be addressed before
integrating this wirelessly delivered DC system into a real medical implant for the clinical
application, which includes size, current level, electrodes’ layout, and sealing. The size is the
primary concern since most commercial electronic implants are quite small. For example, the
typical diameter of a cochlear implant is approximately 2 cm, and the volume of pacemaker ranged
from 6 cm3 to 35cm3. Our in vitro wirelessly delivered DC treatment system includes a rigid
receiver coil of 5 cm diameter, an adjustable rotary resistor (1 cm diameter x 3 cm height) and
several wires as an internal circuit, which is very difficult to reduce the size directly. Hence, we
need to re-design the new internal circuit with a simplified and smaller structure. The layout of
electrodes is another important factor for designing a device since this could directly affect the
treatment efficiency of the device. In our in vitro system, the PDMS blocks with biofilm were
placed between two electrodes in a petri dish (we called “sandwich” electrode), and the biofilm
was fully covered by an electric field between two electrodes (Figure 13). However, the actual
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location of biofilm in vivo is usually on the outside shell of the implanted device, and it is
impossible to install extra electrodes to cover the entire surface area of the device with the electric
field in vivo. Therefore, we need to find new layouts of electrodes to establish a stable electrical
field on the outside shell of the device. The chosen layout of the electrode is expected to not only
obtain the best treatment effect to eradicate biofilms but also fit the structures of implant devices.
The reliability of the system (sealing, strength, et. al) should also be considered to make the system
has no leak.
To satisfy all the requirements mentioned above, we engineered a prototype device by referring to
the structure of the cochlear implant and pacemaker. The device could receive the surrounding
magnetic field wirelessly and then convert back to DC on its surface. This DC was expected to
have a similar killing effect on the biofilms formed on the device as demonstrated in vitro
experiments in Chapter 3. To examine the killing effects of the prototype device with different
designs, we tested the function of these devices in killing P. aeruginosa and S. aureus biofilm cells
both in in vitro and ex vivo model with porcine skin.

4.3 Method and materials
4.3.1 Simulation of the electric field with COMSOL
To obtain the best design of the prototype device, the distribution of electric fields in different
layouts and shapes of the devices was analyzed using COMSOL Multiphysics (COMSOL Inc.,
Stockholm, Sweden) (Table 1). The simulations were done in the AC/DC model. Based on the
results of our previous research, the potential of the electrode in the simulation was set as 1.0 and
-0.9 V for anode and cathode, respectively

24

. The distribution of electric potential and current
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density between electrodes are plotted as colored surface and arrows map, respectively. The
boundaries of simulation were set as electrical insulation.
Table 1. The list of different shapes and layouts were simulated by COMSOL.
The shape

The layout of electrodes

The dimension

Oval

One electrode on each side

7 x 5 x 1 cm (L x W x H)

Oval

Circular electrode on side, square

7 x 5 x 1 cm

electrode on center
Square

One electrode on each side

5 x 5 x 1 cm

Square

Circular electrode on side, square

5 x 5 x 1 cm

electrode on center
Round

One small electrode on each side

Diameter: 4.5 cm, Height: 1 cm

Round

One large electrode on each side

Diameter: 4.5 cm, Height: 1 cm

Round

Circular electrode on side, square

Diameter: 4.5 cm, Height: 1 cm

electrode on center
In vitro setup

One electrode on each side of the petri

Diameter of petri dish: 3.5 cm

dish

4.3.2 Fabrication of the prototype device
The case of the prototype device was created by 3D printing. The material and working
parameters of 3D printing are listed below:
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Table 2. The working parameters in the 3D printing of the case.
Infilled ratio

100%

Layer thickness

0.09 mm

Resolution

Maximum ratio

Material

Polylactic acid (PLA)

The printed case contained two components: the chamber and the cover lid. The receiver module
of the wirelessly delivered DC (coil and rectifier chip) was fixed in the chamber by adhesive tapes,
and then covered by a lid and sealed with food-grade silicone sealant (ASI 502, American Sealants
Inc, Fort Wayne, IN, USA). The electrodes were fixed on the outside of the case with the same
silicone sealant. Several small holes (< 1mm of diameter) on the case were punched by a heated
needle (21 gauge) to introduce copper wire to connect the inside module and outside electrodes,
which were also sealed by silicone sealant.
4.3.3 Treatment of biofilms with the prototype device in vitro
For the in vitro tests, the PDMS blocks with P. aeruginosa or S. aureus biofilm were placed on
top of the device case as shown in Figure 11. Then the whole device with attached biofilms was
immersed in 0.85 % NaCl solution in a petri dish. The coil of the power transmitter unit was placed
under the bottom of the petri dish to deliver DC wirelessly. The current density was set to be 6
µA/cm2 (based on cathode area). The biofilm samples were treated for 6 h, and the viability of
biofilm cells was determined by counting CFU.
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4.3.4 Treatment of biofilms with the prototype device in an ex vivo model with porcine skin
The ex vivo model was adapted from a previous study designed for a study of the surgery site of
the cochlear implant

31, 32

. It was composed of a 3D-printed PLA housing (50 mm diameter, 14

mm depth) to mimic the bone tissue that holds the cochlear implant. The prototype device was
fixed into the housing by silicone sealant and immersed into a 0.85% NaCl solution (Figure 12).
Before treatment, the PDMS blocks with P. aeruginosa or S. aureus biofilms were placed on top
of the device as done in the in vitro test. Then the device was covered with a piece of porcine skin
(1.0 – 1.2 mm thickness) purchased from a local grocery store and approved by Syracuse
University (IACUC#: P4-18) and sterilized by UV for 2 hours on each side. The porcine skin was
used to mimic the human skin that covered the cochlear device after surgery. The fat tissue of
porcine skin had been prepared as described by Ackermann et al.

33

to UV sterilization. The coil

of the power transmitter unit was put on the top of the porcine skin and aligned to the receiver coil
in the prototype device to delivery DC wirelessly. The biofilm samples were treated for 6 h with a
current level of 6 µA/cm2, and the viability of biofilm cells was determined by counting CFU.
4.3.5 Statistical analysis
All data are presented as a mean ± standard deviation. Statistical significance was assessed with
one-way or two-way ANOVA followed by Tukey test. Results with p < 0.05 were considered
statistically signiﬁcant. All analyses were performed using SAS 9.4 software (SAS Institute, Cary,
NC, USA).
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4.4 Results
4.4.1 Distribution of the electric field with different layouts and the shapes of the prototype
device
According to the results of COMSOL simulation, the electric field distribution on the oval-shaped
device was fairly uneven among the different locations with varying distances from the electrodes.
For the layout of the sandwich electrodes, the higher electric potential difference located on the
center of the device surface, and the little current was observed on the regions far away from the
electrodes (Figure 1). When replacing the flat cathode with a circular design that can fully cover
the vertical side around the device and using a small (2 x 1 cm) anode in the center of the device’s
surface (“circular/center” layout), the electric field on the device’s surface was still uneven. For
example, the region of minor ax had higher potential difference compared to the region of the
major ax that was farther from the anode (Figure 2).
The case of square shape had more uniform electric field distribution on the device surface for
both layouts (sandwich and circular/center). Although there was minor electric current outside the
device surface within the flat side of the electrodes (Figure 3), the circular/center layout keep the
entire electric current on the device surface (Figure 4). The square shape device had a challenge in
sealing, especially in the corner regions, which could lead to leaking. This can cause possible
issues in real manufacturing. Additionally, the square-shaped design was abnormal because the
rather sharp edge may cause tissue damage or discomfort.
The round-shaped device had the most uniform distribution of electric field on the entire device
surface among the three shapes simulated, especially for the round-shaped case with the
circular/center layout (Figure 7). The sandwich layout had electric current going outside of the
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device parameter (Figure 5&6), while the circular/center layout concentrated the electric current
within radius of the device. No sealing problem was encountered.
Test of the prototype devices also showed that the circular/center layout had a more uniform killing
effect on biofilm cells than the sandwich layout. For example, when treating P. aeruginosa PAO1
biofilm cells on the oval-shaped device with the sandwich layout, the viability of biofilm cells that
were close to the anode side was reduced by approximately 3 ± 0.5 logs (p = 0.006) ; but only
weaker killing was observed for two biofilm cells closed to the cathode (1.8 ± 0.4 logs, p = 0.006),
while the viability of another two biofilm cells closed to the cathode had no significant change (p >
0.05) (Figure 8). The round-shaped device with sandwich layout also had varying killing effects
on biofilm samples at different locations (3 – 4.3 logs, p <0.001) (Figure 9). When replacing the
sandwich design with the circular/center layout, the viability of biofilm cells was reduced more
evenly (Figure 11). This is consistent with the simulation results that demonstrate even distribution
of the electric field across the device surface.
4.4.2 Evaluating the prototype device in vitro and ex vivo for biofilm control
Based on the results of COMSOL simulation and preliminary DC treatment, the final version of
the device was selected to have contained a round-shaped case (45 mm of diameter) with a square
TGON anode (1 x 1 cm) in the center and a stainless steel cathode (approximately 1 x 14 cm)
around the vertical side. This layout generated a well-defined electric field and high current density
on the surface of the device (Figure 10). The total volume of the device was 25 cm3, close to that
of the commercial pacemaker devices. A customized copper receiver coil with a diameter of 30
mm and thickness of 2 mm was installed in the device’s chamber. The coil was connected to a
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rectifier chip (3 x 1 x 0.5 cm) by soldering. Both TGON and stainless steel electrodes on the outside
of the device were also connected to the chip by copper wires (26 gauge).
The prototype device was evaluated by treating P. aeruginosa and S. aureus biofilms on PDMS
blocks placed on top of the device. By supplying power wirelessly to the device, we generated DC
at 6 µA/cm2. With a 6 h treatment in vitro, there were 1.5 ± 0.2 (p < 0.001) and 3.0 ± 0.1 logs (p =
0.003) of the reduction of the viability of P. aeruginosa and S. aureus biofilm cells, respectively
(Figure 11). When the whole system was tested in the ex vivo model, the viability of P. aeruginosa
and S. aureus biofilm cells were reduced to 1.0 ± 0.14 (p = 0.03) and 2.6 ± 0.8 logs (p <0.001),
respectively (Figure 12).

4.5 Discussion
In the proof-of-concept test, a strong and uniform electric field was established between the anode
and cathode, covering the entire PDMS blocks with biofilm samples (Figure 13). The viability of
biofilm cells on each PDMS was reduced equally after treatment. Because the implanted devices
have critical functions, the design of the prototype must promise its reliability and reusability for
repeated use and consistent performance. Hence, the prototype device should not have any
corrosion-sensitive material as the anode because it could decrease the lifetime of the device and
release substrates that have potential impact on to surrounding tissues. Additionally, the device
should be easy to seal to prevent the leakage of body fluid, which would cause short circuit and
failure of the device.
The circular/central layout of the electrodes was chosen based on the results of the COMSOL
simulation. Although the sandwich layout with flat electrodes is easier for fabrication, the electric
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field is more dispersed which can lead to lower current density on the device surface, and
consequently reduce the killing efficacy of DC treatment. The circular/central layout had a more
concentrated electric field on the device surface; therefore, it could generate higher current density
on the device. This should improve the efficiency of treatment and safety to the host tissues.
For the shape of the device, the square device was excluded because of poor sealing on the corners
and uneven electric potential difference on the device’s surface. The oval device was also
abandoned from further study because of the uneven distribution of the electric field, which led to
the uneven killing effects on biofilm cells. In comparison, the round-shaped device was easy to
construct, and the distribution of the electric field on the round surface was more uniform than the
other two designs based on the simulation result of COMSOL. The round-shaped device had equal
killing effects on the biofilm cells presumably because of its uniform electric field.
The electrode’s materials should also be well considered in prototype design. According to the
results of the previous proof-of-concept experiments in Chapter 3, the stainless steel electrodes
had stronger killing activities against P. aeruginosa than S. aureus planktonic cells, while the
graphite-based TGON electrodes were more efficient in killing S. aureus biofilm cells. There was
a large number of metal precipitates using stainless steel electrodes when the current level was
more than 60 µA/cm2. The steel anode is oxidized and produces metal ions (Fe, Cr, et al.) during
DC treatment 22, 23, 34 (called Galvanic corrosion) 35. These ions precipitated as solid particles if the
solution is basic or contains certain cations. As a result, the device surface and treatment solution
were both stained yellow or brown after treatment. To prevent this and keep the device and tissue
clean in real applications, the TGON electrodes were chosen to replace steel as the anode because
of its high resistance to electrochemical corrosion. TGON is graphite materials and thus there were
no metal particles produced. The device surface was still clean after treatment 24. In our study, we
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used small TGON square as the anode and stainless steel as the cathode to ease the manufacturing
and avoid corrosion of either electrode during treatment.
The final version of the prototype device had a round case that had approximately 25 mL of volume
and 12 cm2 of surface area. This size was close to commercial pacemaker implants (20-25 mL).
The layout of electrodes included a circular steel electrode on the side of the device and a square
TGON electrode on the center of the top surface. The wirelessly delivered DC showed 1.5 and 3
logs killing at 6 µA/cm2 for P. aeruginosa and S. aureus biofilm, respectively, which demonstrated
the potential of this platform technology for controlling infections associated with implanted
medical devices. The treatment result of using the ex vivo model also had 2.6 logs killing effect on
S. aureus biofilm cells on the surface of the device. This suggests that the skin tissue would not
reduce the efficiency of wireless delivery of DC significantly, which is consistent with the result
of the proof-of-concept experiments in vitro.

4.6 Conclusion
In summary, we have designed and engineered a prototype device with the function of wireless
delivery of DC based on the comparison of different device designs with varying shapes, electrode
layouts and electrode materials. The selected design of the device demonstrated good efficacy in
killing both P. aeruginosa and S. aureus cells in in vitro and ex vivo model. The results demonstrate
that this is an effective platform for investigating the in vivo treatment using wirelessly delivered
DC in the future.
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4.8 Figures

Figure 1. Overhead view of distribution of electric potential (color surface) and current density
(arrows map) on the surface of the oval-shaped device with the sandwich layout of electrodes.
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Figure 2. Overhead view of distribution of electric potential (color surface) and current density
(arrows map) on the surface of the oval-shaped device with the circular/center layout of electrodes.
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Figure 3. Overhead view of distribution of electric potential (color surface) and current density
(arrows map) on the surface of the square-shaped device with the sandwich layout of electrodes.
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Figure 4. Overhead view of distribution of electric potential (color surface) and current density
(arrows map) on the surface of the square-shaped device with the circular/center layout of
electrodes.
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Figure 5. Overhead view of distribution of electric potential (color surface) and current density
(arrows map) on the surface of the round-shaped device with the circular/center layout of
electrodes.
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Figure 6. Overhead view of distribution of electric potential (color surface) and current density
(arrows map) on the surface of the round-shaped device with the small sandwich layout of
electrodes.
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Figure 7. Overhead view of distribution of electric potential (color surface) and current density
(arrows map) on the surface of the round-shaped device with the large sandwich layout of
electrodes.
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(A)

(B)
Figure 8. Experimental setup and killing effects of S. aureus biofilms at different locations of the
oval-shaped device with the sandwich layout of electrodes. (A): The experimental setup of S.
aureus biofilm samples on the surface of a prototype device. (B): Viability of S. aureus biofilm
cells on the surface of the prototype device after treatment with wirelessly delivered DC (12
µA/cm2) for 6 h.
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(A)

(B)
Figure 9. Experimental setup and killing effects of S. aureus biofilm on different locations of the
round-shaped device with flat-side electrodes. (A): The experimental setup of prototype device.
(B): The viability of S. aureus biofilm on the surface of the prototype device after treatment with
wirelessly delivered DC (170 µA/cm2) for 6 h.
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Figure 10. The final design of the round-shaped prototype device with a circular cathode and center
anode. (A): The internal circuit including receiver coil, rectifier chip, and internal resistor. (B) The
layout of electrodes on the surface of the prototype device.
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(A)

(B)
Figure 11. In vitro test of the selected prototype device. (A): Schematic of the experimental setup.
The PDMS blocks with biofilm were placed on the top of the device and around the central
electrode for DC treatment. (B): Viability of P. aeruginosa and S. aureus biofilm cells after
treatment with 6 µA/cm2 for 6 h in vitro. (***, p < 0.001; **, p = 0.01)
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(A)

(B)
Figure 12. Ex vivo test of the selected prototype device. (A): Schematic of the experimental setup
in model. The device was fixed into the 3D-printed cavity and covered with porcine skin. The
wireless power transmitter was placed on the top of the skin. (B): Viability of P. aeruginosa and S.
aureus biofilm cells after treatment with 6 µA/cm2 for 6 h in ex vivo model. (***, p < 0.001; *, p
< 0.05)
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Figure 13. COMSOL simulation of electric potential (color surface) and current density (arrows
map) distribution in a petri dish with the flat stainless steel electrode (0.5 cm width, 0.01 cm
thickness) positioned on opposite side. Three PDMS coupons with biofilm were placed in the
electric field between two electrodes. The total DC level was approximately 100 µA.
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Chapter 5
Killing mechanism of DC treatment
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5.1 Abstract
Direct electric current (DC) has been reported in many studies for its biocidal effects on pathogenic
microorganisms in the presence or absence of antimicrobials. The reactive oxygen species (ROS)
and metal ions produced by the electrochemical reaction during DC treatment are believed to
contribute the killing effects, although only the bactericidal effect of hydrogen peroxide has been
reported in the previous studies. In this Chapter, the killing mechanism of DC treatment was
investigated by comparing the killing effects of different electrochemical products, such as
hypochlorite, hydrogen peroxide, iron, and chromium ions. According to the results, we find that
the DC treatment using TGON electrodes killed biofilm cells by generating hypochlorite from the
anode, which depended on the concentration of sodium chloride in the solution. The DC treatment
using stainless steel electrodes could induce Fenton reaction by the metal ions from anode and
hydrogen peroxide from the cathode to produce free radicals that have the potent bactericidal effect.
By understanding the killing mechanism of DC treatment, it will be helpful for improving the
device design and assessment of cytotoxicity to host tissues.

105

5.2 Introduction
The first study of bacterial control by electric current was reported in 1915 by Beattie 1, who
applied alternating current (AC) at 3000 – 4000 V to eradicate microorganisms from milk. Later,
Rosenberg

2

found that E. coli could be killed with 2 A of AC using platinum electrodes. The

biocidal effects of low-level AC to bacteria were also reported by Pareilleux et al.

3

that the

viability of E. coli was reduced after treatment from 10 to 200 mA of AC using stainless-steel
electrodes.
Compared to AC, direct current (DC) received more attention as an alternative antimicrobial
method. Rowley 4 first showed the biocidal effects on E. coil using 1- 140 mA DC conducted with
platinum electrodes in the 1970s. Then Baranco 5 reported the reduction of the viability of S. aureus
cells after treatment with 400 µA DC using silver, platinum, gold or stainless steel electrodes. In
general, DC requires lower levels than AC to achieve significant biocidal effects, and this is more
suitable for application in vivo, although in vivo treatment may require higher current levels. For
example, Ehrensberger et al.

6, 7

reported that the number of viable S. aureus cells were reduced

by 90% after treatment with 1 mA DC in the rabbit model although they obtained more than 2 logs
of killing effect on S. aureus cells with lower DC level in vitro. In addition to the effects of DC
alone, the synergy between DC and antibiotics has also been reported. For example, more than 2
additional logs of killing effects were observed in the concurrent treatment of E. coli cells with 6
mA/cm2 of DC and gentamicin and oxytetracycline compared to DC treatment alone 8. Costerton
9

et al. also reported that 100 µA/cm2 DC could promote killing efficiency of tobramycin to P.

aeruginosa biofilm.
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The killing mechanism of electric current treatment is still not well understood although several
theories have been proposed. In 1962, Brandt et al.

3, 10

first speculated that the free radicals

generated by electric treatment have a bactericidal effect. For the treatment with high-level electric
currents, cell membranes are believed to be permanently damaged by current-associated high
energy, leading to cells’ death 11. Lower level DC may cause bacterial killing with electrochemical
products 12, 13. A number of possible redox reactions could occur at the interface between electrode
and electrolyte solution during electrolysis:
Oxidation reactions on anode: 14
2𝐻2 𝑂 → 4𝐻 + + 𝑂2 + 2𝑒 −
𝐹𝑒 → 𝐹𝑒 2+ + 2𝑒 −
𝐹𝑒 2+ → 𝐹𝑒 3+ + 𝑒 −
𝐶𝑟 → 𝐶𝑟 3+ + 3𝑒 − (Trace in steel anode)
2𝐶𝑙 − → 𝐶𝑙2 + 2𝑒 −
𝐶𝑙 − + 𝐻2 𝑂 → 𝐻𝐶𝑙𝑂 + 2𝑒 − + 𝐻 +
𝐶𝑙2 + 2𝐻2 𝑂 → 2𝐻𝐶𝑙𝑂 + 2𝑒 − + 2𝐻 +
Reduction reactions on cathode:
𝐻2 𝑂 + 2𝑒 − → 𝐻2 + 2𝑂𝐻 −
𝑂2 + 2𝐻 + + 2𝑒 − → 𝐻2 𝑂2
𝑂2 + 𝐻2 𝑂 + 𝑒 − → 𝐻𝑂2 ∙ +𝑂𝐻 −
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𝑂2 + 2𝐻2 𝑂 + 2𝑒 − → 𝐻2 𝑂2 + 2𝑂𝐻 −
Redox reactions in electrolyte solution: 15
𝐹𝑒 2+ + 𝐻2 𝑂2 → 𝐹𝑒 3+ + 𝑂𝐻 ∙ +𝑂𝐻 −
𝐹𝑒 3+ + 𝐻2 𝑂2 → 𝐹𝑒 2+ + 𝑂𝑂𝐻 ∙ +𝐻 +
2𝐹𝑒 3+ + 2𝐻2 𝑂 → 2𝐹𝑒 2+ + 𝐻2 𝑂2 + 2𝐻 +
The metal anode, especially silver, copper, and steel, are oxidized to release metal ions (Ag+,
Cu2+/Cu+, Cr3+, Fe2+/Fe3+, et al.) during DC treatment 13. These ions could accumulate and interrupt
cell metabolism. Moreover, the metal ions could move ion flow in an electric field, which was
found disrupt the integrity of the cell membrane 12, 13. Based on electrochemistry, radical oxygen
species and free radicals could be generated from the redox reactions at the electrodes. However,
it is difficult to directly prove since many of those species have a short life and can react with cells
immediately. Hydrogen peroxide (H2O2) is one of the few radical oxygen species that have been
verified as generated during electric treatment. H2O2 could disrupt the structure and permeability
of the cell wall and membrane 16. The concentration of H2O2 close to the electrode surface range
from 0.2 µM to more than 20 µM when the current density increases from 5 to 40 µA/cm2

17

;

however, this concentration decreases quickly towards zero over the distance from the electrode
18

. Another reported radical oxygen species generated in DC treatment is hypochlorite when the

electrolyte solution contains chloride ions. The chloride ions are oxidized on the anode to produce
chlorine and hypochlorite

19

. Hypochlorite could disrupt many activities of bacteria, such as

oxidative phosphorylation and sulfhydration, as well as DNA synthesis 20. To evaluate how those
electrochemical products could affect the killing results of wireless DC treatment of biofilm cells,
we conducted a series of experiments using DC and different electrochemical products in this study
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to mimic the actual electrochemical reactions during DC treatment and evaluate the killing effects
of these reactions.
We reported that the activities of some antibiotics (e.g. tobramycin) could be enhanced in the
presence of an electric field conducted by stainless steel electrodes, but not graphite electrodes 12.
We speculated that this may result from synergistic interactions between metal ions from stainless
steel and antibiotic molecules. For example, tobramycin could bind to ribosome RNA and interrupt
protein synthesis in P. aeruginosa

21

. We suspected the metal ions may form a complex with

tobramycin molecules to increase its affinity to RNA, leading to the enhanced killing effect on P.
aeruginosa cells. The hammerhead ribozyme cleavage reaction is an ideal model to study the
interactions between RNA molecules and antimicrobial agents since the hammerhead ribozyme
has a small, well-defined structure 22 23. In this study, we utilize the hammerhead ribozyme system
to investigate the interaction between Cr (III) (Tobramycin) complex and RNA in vitro.

5.3 Methods and materials
5.3.1 Killing assay of P. aeruginosa biofilm with metal ions, sodium hypochlorite and
hydrogen peroxide
The P. aeruginosa biofilm samples on PDMS were cultured in LB medium for 24 hours followed
by washing with 0.85% NaCl solution twice. Then, the biofilm samples were placed in a petri dish
and soaked in 3 mL of 0.85% NaCl solution mixed with different chemicals including sodium
hypochlorite (5%, Fisher Scientific, Hampton, NH, U.S.), hydrogen peroxide (30%, Fisher
Scientific, Hampton, NH, U.S.) and ferric chloride (1%, Fisher Scientific, Hampton, NH, U.S.).
The concentration of chemicals is listed in Table 1. The biofilms were treated with these chemicals
109

at room temperature for 3h. After treatment, the biofilm cells were harvested by following the
same methods described in Chapter 3 and the viability was determined by counting CFU.
5.3.2 DC treatment of P. aeruginosa biofilms in different concentrations of NaCl solution
P. aeruginosa biofilm samples on PDMS were prepared and washed as described previously. Then
they were placed between two TGON or stainless-steel electrodes in a petri dish. The electrodes
were connected to a potentiostat (Potentiostat WaveNow, Pine Research Instrumentation, Raleigh,
NC, U.S.) that applied 30 µA/cm2 DC to a treatment facility for 3 h. During DC treatment, the
biofilm samples were soaked in the electrolysis solutions with different concentrations of sodium
chloride (Table 1). Fe (III) ions were also added into electrolysis to explore the possible synergistic
effect. After treatment, the biofilm cells were harvested following the same methods and cell
viability was determined by counting CFU. The control was biofilm cells without DC treatment.
Table 1. Conditions tested for treatment of P. aeruginosa biofilms in single chamber system
Condition No.

NaCl % Electrodes

DC level µA/cm2

Other chemicals in solution

1

0.85

TGON

30

-

2

0.01

TGON

30

-

3

0.001

TGON

30

-

4

0.001

Stainless steel

30

-

5

0.85

Stainless steel

30

6

0.85

-

-

0.1% NaOCl

7

0.85

-

-

0.01% NaOCl

8

0.85

-

-

0.001% NaOCl

9

0.85

-

-

2 mg/L H2O2

10

0.85

-

-

20 mg/L H2O2

11

0.85

-

-

200 mg/L H2O2
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5.3.3 DC treatment of P. aeruginosa biofilms in the dual chamber system
To prevent the interference between anode and cathode during DC treatment, a similar test of P.
aeruginosa biofilms was also conducted in a dual chamber system that was used in previous
research

13, 24

. This system contained two chambers with the only one single electrode in each

chamber filled with 0.85% NaCl solution. A capillary tubing containing 0.85% NaCl solution was
used as a salt bridge between the two chambers and complete the electric circuit. The P. aeruginosa
biofilm samples were placed both in anode and cathode chambers. Then 30 µA/cm2 of DC was
applied to the system using a potentiostat in 3 h. After treatment, the viability of biofilm cells was
determined by counting CFU.
5.3.4 DC treatment of P. aeruginosa planktonic cells in the presence of chromium (III)
To investigate if chromium ions have bactericidal effects in the electric field, P. aeruginosa PAO1
planktonic cells were treated with chromium (III) ions in the presence and absence of DC. The
overnight planktonic cells culture was washed with DI water twice to remove chloride and
dissolved organic components. Then the cells were resuspended in 3 mL 0.001% NaCl solution to
a final cell density of 108 per mL in the petri dish. Two TGON electrodes were inserted into the
petri dish and connected with a potentiostat to apply 60 µA/cm2 DC to the treatment chamber for
1 hour. After treatment, the viability of planktonic cells was determined by counting CFU.
The similar test was also conducted in the dual chamber system mentioned above. The washed P.
aeruginosa cells were resuspended in two chambers followed by adding 10 µM CrCl3 (Acros
Organics, NJ, USA). Then 20 µA/cm2 of DC was applied to the system using a potentiostat in 1 h.
After treatment, the viability of planktonic cells was determined by counting CFU.
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5.3.5 DC treatment of S. aureus planktonic cells in agarose gel
The agar matrix could limit the motility of bacterial cells allowing one to observe which area
between anode and cathode has strong killing effects on the cells. In this study, the overnight
planktonic cells culture was washed with 0.85% sodium chloride solution twice followed by
mixing with sterilized 1.0% agarose solution containing 0.85% sodium chloride (Fisher Scientific,
Hampton, NH, U.S.) at approximately 40 °C. Then the mixture was added into a 3 mL cuvette
with a stainless steel electrode placed on each side. After the gel was set, the electrodes were
connected to a potentiostat to apply 60 µA/cm2 DC for 1 hour. After treatment, the agarose gel
with cells was stained by the Live/Dead staining kit (Thermofisher, Waltham, MA, USA) for 15
min. The cell viability was determined using fluorescence microscopy.
5.3.6 Hammerhead ribozyme-catalyzed cleavage reaction
To investigate the mechanism of synergy between chromium ions and antibiotics in bacterial
killing, we conducted a hammerhead ribozyme-catalyzed cleavage test using Cr (III) ion and
tobramycin. The experiment materials and procedure are similar to that described in C. S. Chow’s
report 23. Briefly, the hammerhead ribozyme and fluorescein-labeled RNA substrate, which shared
the same sequence as Chow’s experiment, were obtained from Integrated DNA Technologies
(Coralville, IA, USA). Other reagents involved included 0.4 M MgCl2 (Amresco, Solon, OH,
USA), 6.4 mM tobramycin (Tokyo Chemical Industry, Japan), 6.4 mM CrCl3 (Acros Organics, NJ,
USA), and 1 M Tris-HCl buffer (pH 7.5). The gel was made with 20% 37.5:1 acrylamide–
bisacrylamide solution, 10% (w/v) ammonium persulfate in H2O, and TEMED (N, N, N’, N’tetramethyl ethylenediamine). The gel running buffer was 10X TBE (900 mM Tris base, 90 mM
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boric acid, 25 mM EDTA, pH 8.3). The loading buffer consisted of 16 M urea, 30% glycerol and
1X TBE.
First, the hammerhead ribozyme (30 pmol) was mixed with RNase free water and 1 µl Tris-HCl
buffer in 1.5 mL centrifuge tubes, followed by boiling for 90 seconds. After the mixture cooled
down to room temperature (in 10 minutes), a mixture of 1 µL tobramycin (final concentration 320
µM) and 1 µL CrCl3 (final concentration ranged from 320 µM to 32 µM) were added into each
tube. Next, the fluorescein-labeled RNA substrates (100 pmol) were added into mixture solution
followed by 1 µL 0.4 M MgCl2. There were one negative control without hammerhead ribozyme
and one positive control with neither tobramycin nor CrCl3. Besides, to compare with inhibitory
effects of tobramycin or Cr3+ alone, another four control samples with the same concentration of
tobramycin or CrCl3 alone were set up. The final volume of the mixture in each tube was 20 µL.
The mixtures were incubated at 37°C for 1 h. The loading buffer was added to mixtures after
reaction completion, and then they were stored at -80°C immediately after boiling for 90 seconds.
The 20% polyacrylamide (37.5:1 acrylamide–bisacrylamide) gel was prepared following Chow’s
protocol 23. The gel was run at 100 V in 1X TBE buffer for approximately 2 h (Mini-PROTEAN®
Tetra Cell system, Bio-Rad Laboratories, Hercules, CA, USA). Then the gel was imaged using a
Bio-Rad Gel Doc XR+ system with Image-lab software (Bio-Rad Laboratories, Hercules, CA,
USA).
The relative quantity of RNA in each band was calculated based on the strength of fluorescence
using the negative control as a reference. The ratio of cleavage was calculated by the equation
below:

𝑅𝑎𝑡𝑖𝑜 𝑜𝑓 𝑐𝑙𝑒𝑎𝑣𝑎𝑔𝑒 =

𝑟𝑒𝑙𝑎𝑡𝑖𝑣𝑒 𝑞𝑢𝑎𝑛𝑡𝑖𝑡𝑦 𝑜𝑓 𝑝𝑟𝑜𝑑𝑢𝑐𝑡𝑠 (𝑙𝑜𝑤𝑒𝑟 𝑏𝑎𝑛𝑑𝑠)
𝑟𝑒𝑙𝑎𝑡𝑖𝑣𝑒 𝑞𝑢𝑎𝑛𝑡𝑖𝑡𝑦 𝑜𝑓 𝑠𝑢𝑏𝑠𝑡𝑟𝑎𝑡𝑒𝑠 (𝑢𝑝𝑝𝑒𝑟 𝑏𝑎𝑛𝑑𝑠)
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The ratio is inversely correlated with the inhibitory.
5.3.7 Statistical analysis
All data are presented as a mean ± standard deviation. Statistical significance was assessed with
one-way or two-way ANOVA followed by Tukey test. Results with p < 0.05 were considered
statistically signiﬁcant. All analyses were performed using SAS 9.4 software (SAS Institute, Cary,
NC, USA).

5.4 Results
5.4.1 Killing effect of DC in solutions with different concentrations of sodium chloride
According to the results of killing assay under different conditions, TGON electrodes showed
dosage-dependent killing effects based on the concentration of sodium chloride in the solution.
For example, the viability of P. aeruginosa biofilm was reduced by 1.8 ± 0.1, 1.4 ± 0.07 and 0.8
± 0.09 logs (p = 0.01) with 0.85%, 0.1%, 0.01% and 0.001% NaCl, respectively. However, the
treatments using a stainless steel electrode did not show a significant difference (1.1 ± 0.04 and
1.3 ± 0.3 logs, p > 0.05) between 0.85% and 0.001% NaCl solution (Figure 1&2).
5.4.2 Killing effect of chlorite and hydron peroxide on P. aeruginosa biofilm
The killing effect of sodium hypochlorite on P. aeruginosa biofilm cells was dosage-dependent,
which was 6.0 ± 0.2, 1.4 ± 0.8 and 0.6 ± 0.2 logs (p < 0.001) in 0.01%, 0.001% and 0.0001%
NaOCl for 6 h treatment (Figure 1). In comparison, H2O2 at 100 mg/L showed only 0.9 ± 0.05 logs
(p < 0.001) killing of P. aeruginosa biofilm cells, while the H2O2 solution of lower concentrations
didn’t show the significant killing effect (Figure 2).
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5.4.3 Killing effect of DC treatment on P. aeruginosa biofilm in dual chamber system
In the dual chamber system, the DC treatment using TGON electrodes showed 2.6 ± 0.2 logs (p =
0.002) killing effect on biofilm cells in anode chamber, while there was no significant killing in
cathode chamber (0.4 log, p >0.05) (Figure 3). The DC treatment using stainless steel electrodes
demonstrated 0.6 ± 0.3 (p = 0.03) and 0.7 ± 0.01 (p = 0.004) logs killing effect on biofilm cells in
anode and cathode chamber, respectively (Figure 4).
5.4.4 The role of chromium ions in the killing mechanism of DC
In previous research, we reported that the stainless-steel electrode could release metal ions during
DC treatment. These ions were found to have bactericidal effects on the cells under an electric
field. To understand if wirelessly induced DC also show similar effects, chromium (III) and Ferric
(III) were tested on P. aeruginosa PAO1 planktonic cells. When P. aeruginosa planktonic cells
were treated with wirelessly induced DC and chromium (III) ions for 1 h, 2.4 ± 0.3 logs of killing
was observed under the condition of concurrent treatment with 60 µA DC/cm2 and 10 µM
chromium (III) ions. In comparison, treatment with 60 µA/cm2 DC or 10 µM chromium (III) ions
alone only showed 0.4 ± 0.2 logs and 0.9 ± 0.2 logs of killing (p = 0.005), respectively (Figure 5).
When the concentration of chromium (III) ions increased to 100 µM, the viability of planktonic
cells was reduced by 6.1 ± 0.2 logs (p = 0.014) with concurrent treatment with 60 µA DC/cm2. But
the chromium (III) ions only exhibited 0.9 ± 0.3 logs of killing (Figure 6).
Similar results of synergetic effects between DC and chromium (III) ions were observed in
concurrent treatment in the dual chamber system. For example, the number of viable P. aeruginosa
planktonic cells was reduced by 2.8 ± 0.05 logs after concurrent treatment with 20 µA/cm2 DC
and 10 µM chromium (III) ions in the cathode chamber (p = 0.002). In comparison, concurrent
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treatment with DC and chromium (III) in anode only showed a 1.0 ± 0.01 log of killing (Figure 7).
Meanwhile, the planktonic cells in anode and cathode chamber were reduced by less than 0.1 logs,
respectively.
5.4.5 The killing effects of DC on S. aureus planktonic cells in agarose gel
Multiple brown bands of precipitate were observed in the middle region of agarose gel between
anode and cathode after DC treatment (Figure 8). The color and density of bands were found
dependent on the duration of treatment. The precipitates could dissolve in the diluted hydrogen
chloride solution. According to the Live/Dead staining images in Figure 9A&B, there were also
several dark bands in S. aureus planktonic cells culture in the agarose gel. In these bands, the
number of live (green) cells dramatically decreased to almost nothing while the dead (red) cells
were more compared to surrounding areas (Figure 9C&D). Furthermore, the locations of dark
bands and precipitate bands overlapped in the agarose gel. These precipitates didn’t show the
bactericidal effect on S. aureus cells in the absence of the electric field when mixed with planktonic
cells and precipitates from the electrolysis solution after DC treatment (Figure 9E).
5.4.6 The enhanced affinity between RNA and tobramycin-chromium (III) complex
The samples with the mixture of 320 µM tobramycin and 320 µM Cr (III) had the lowest ratio of
cleavage (4.2 ± 2.1, p = 0.002), and it raised to 9.3 ± 1.3 and 11.8 ± 3.7 when the concentrations
of Cr (III) reduced to 160 µM and 32 µM, respectively. The sample with tobramycin alone had the
ratio of 14.1 ± 1.7, and the three samples with Cr (III) alone (without tobramycin, concentration
ranged from 320 µM to 32 µM) had a nearly constant ratio of cleavage (15.0 ± 3.2, 15.1 ± 1.0 and
15.2 ± 2.4). Apart from this, the cleavage ratio of the positive control was the highest (21 ± 3.3)
and the negative control was zero (Figure 10&11).
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5.5 Discussion
Hydrogen peroxide generation from both metal and nonmetal electrodes has been well studied.
The killing effect of other electrolysis products from the electrode is still unknown. Compared to
the results of stainless steel electrodes, our study shows that the graphite-based TGON electrodes
may have a different killing mechanism against biofilm cells. We found the killing effect of TGON
electrodes reduced dramatically when replacing 0.85% sodium chloride solution with 0.01% or
0.001% solution during treatment, which was consistent to the killing results of different
concentrations of sodium hypochlorite in the absence of DC. This finding suggests that the
hypochlorite may play an important role in killing bacterial cells with TGON conducted DC
because electrolysis of saline solution can produce chlorine and hypochlorite by anode oxidation
reaction in the presence of chloride ions. The killing effect of stainless steel electrodes wasn’t
affected by the concentration of chloride ions, which may result from different electrochemical
products of metal electrodes during DC treatment. The stainless steel anode could release metal
ions (Fe, Cr, Ni et al.) during the DC treatment due to the oxidation of anode metal, while the
stainless steel cathode could reduce dissolved oxygen to produce hydrogen peroxide. When treated
bacteria cells with stainless steel electrodes in a two-chamber system that could separate the anodic
and cathodic electrolytic products 24, no significant killing effect was observed. This supports our
hypothesis that the killing effect of DC conducted by steel electrodes results from the secondary
products of reactions between electrochemical products of anode and cathode. Interestingly,
hydrogen peroxide also did not show the significant killing effect on biofilm cells in our research
even with a high concentration of 200 mg/L. The measurable level of hydrogen peroxide ranged
from 5 to 40 µM near the electrode surface during DC treatment. However, the concentration in
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bulk solution decreased towards zero over distance 17. This helps explain our finding because the
biofilm samples were approximate 2-3 mm away from both anode and cathode in the treatment
facility.
Chloride is the most abundant anion in humans and an essential element for maintaining cell
homeostasis and transmitting action potentials

25

. It is also required for the immune response

mediated by phagocytes and neutrophils 26. In the 1960s, the antivirus activity of 150 mmol sodium
chloride against mengovirus was reported based on treatment at 37 °C for 2 hours 27. Similar killing
effects were also seen with other chloride compounds, such as potassium chloride, magnesium
chloride. This suggests that the biocidal effects to the microorganism of chloride compounds came
from chlorite anion, not cations. Recently Ramalingam et al.

27

reported that the viral inhibition

was not from sodium chloride directly when treated virus with epithelial, fibroblast and hepatic
cells although the increasing concentration of sodium chloride promoted the effects. Adding
myeloperoxidase inhibitor could reverse the inhibition, which showed that chloride anions could
be converted to other forms of molecules during inhibition procedure. Wang 26 found that chloride
anions could be converted to hypochlorous acid by myeloperoxidase (MPO) in phagosomes. This
reaction needs hydrogen peroxide as the reactant. Both hydrogen peroxide and hypochlorite have
antimicrobial activities as oxidants that target electron transport chain, DNA replication, adenine
nucleotides, metabolic enzymes and unsaturated fatty acids in cells’ membranes 28. Hypochlorous
acid has even more potent effects. Chensey et al.

28

showed that hypochlorous acid had 500 to

1,000 folds higher toxicity to E. coli cells than hydrogen peroxide. In our study, the treatment of
P. aeruginosa biofilms with hydrogen peroxide and hypochlorite showed dosage-dependent
killing effects, although the minimal biofilm killing concentration of hypochlorite was much lower
than hydrogen peroxide. As mentioned in Chapter 2, the major electrochemical products with

118

possible biocidal effect during DC treatment using TGON electrodes were hypochlorous acid and
hydrogen peroxide. Reducing the concentration of sodium chloride in the electrolyte solution can
reduce the generation of hypochlorous acid. According to the result, we found decreasing killing
effect in DC treatment with the same current level conducted by TGON electrodes. All of these
findings suggest that the hypochlorous acid generated by TGON anode is the primary bactericidal
agent during DC treatment using TGON electrodes.
The bactericidal mechanism of DC treatment using stainless steel electrodes is more complex than
TGON since there are more electrochemical reactions involved. Because steel is not a corrosion
resistant material, the anode itself is easily oxidized and metal ions are released when applied with
positive potential. Appropriate metal ions are essential elements required for cell metabolism;
however, an excess amount of metal ions could also be toxic to bacterial cells, since they could
interfere with normal metabolic process by improper metalation of metalloproteins with the
unwanted metal

29

. Besides, the negative-charged bacterial membrane has high affinity to those

metal cations. Although binding to metal cations on the membrane may not directly kill cells, these
ions alter the normal net charge across the cell membrane and interfere the membrane functions 30.
Based on our test, treating biofilm cells with metal ions (such as chromium (III)) alone only
showed a slight reduction in cell viability. This suggests that other more potent biocidal agents
may exist during DC treatment, or the movement of ions may be essential for DC-mediated killing.
Hydrogen peroxide is produced during DC treatment despite stainless steel or TGON electrodes,
but it couldn’t eradicate biofilm effectively if the concentration was lower than 100 mg/L, which
is much higher than the concentration (5 – 40 µM) measured in hydrolysis process with 40 µA/cm2
DC

17

. However, if metal ions and hydrogen peroxide are mixed, they could induce the Fenton

reaction that could produce free radicals, such as hydroxyl and carboxylic radicals. These free

119

radicals are powerful oxidant with the ability to mineralize most organics, which could kill
bacterial cells quickly by disrupting cell membrane and causing cell lysis 13. Anfruns-Estrada et al.
15

had reported that by treating with 20 mA/cm2 in a cylindrical tank reactor in presence of 0.25

mM FeSO4, the viability of E. coli cells in wastewater could be reduced by 5 logs. They contributed
the killing effect to the electro-Fenton reaction that occurred between added ferric ions and
hydrogen peroxide produced by the electrodes. In our study, DC treatment can also generate metal
ions and hydrogen peroxide from anode and cathode, respectively. When contacting with each
other in the solution, the Fenton’s reaction could occur. Although it’s difficult to detect Fenton
reaction products directly due to a short life and rapid reactions of these species, we obtained
indirect evidence supporting the presence of Fenton reaction. For example, DC treatment with the
dual chamber system using stainless steel electrodes didn’t show the significant killing effect on
bacterial cells. The products of anode and cathode in the dual chamber system are still the same as
the single chamber, but they are isolated in different chambers and can’t contact each other to
initiate Fenton reaction. And neither metal ions nor hydrogen peroxide is a potent biocidal agent
alone against biofilms. As a result, the killing effect decreased in the dual chamber system.
Moreover, when we replaced 0.85% sodium chloride electrolyte solution with 0.85% sodium
chloride agar, we observed be a precipitate band in the middle region of agar between anode and
cathode after DC treatment. We speculated this resulted from the diffusion of anode and cathode
products. Once they meet each other in the middle region of agarose, the Fenton reaction occurred
and left precipitate products trapped in the agarose. Interestingly, if the planktonic cells were added
into ager and carried on the same treatment, a dark zone without any live cells was seen at the
same location with the precipitate band in the agar. This region may have Fenton reaction during
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DC treatment so that the bacterial cells in the same location were effectively killed by free radicals
immediately after being produced.
Another interesting finding was the killing effects of chromium (III) ions in the presence of DC.
The stainless steel contains approximately 16-18 % of chromium. The chromium is the essential
element to protect steel from corrosion since it could be oxidized earlier than ferric ions and form
a protective coating on the steel surface. Hence, chromium ions should be produced earlier than
ferric during DC treatment. Chromium (III) is also a well-known nutrient element for human,
which is essential for insulin synthesis. However, chromium (III) is toxic to bacteria cells. Fathima
et al.

31

reported chromium (III) could damage cell membrane and DNA by generating ROS,

although we didn’t find the significant biocidal effect when mixed chromium (III) with planktonic
cells. Chromium could induce a Fenton-like reaction in presence of hydrogen peroxide

32

and

produce hydroxyl radicals. Our study shows the evidence that Fenton-like reaction may happen
during DC treatment. If we added chromium into the electrolyte solution, the significant increase
in the killing effect was observed, which suggests that there should be a large number of
bactericidal agents produced in the solution. Besides, when the anode and cathode chamber were
separated, adding chromium only increased the killing effects in the cathode chamber. All of these
findings support the existence of the Fenton-like reaction induced by chromium (III) during DC
treatment, and it may have a significant role in the bactericidal effect of DC treatment using
stainless steel electrodes.
Like hydrogen peroxide, hypochlorite can react with ferric ions to produce hydroxyl and chlorine
radicals 33. These products from Fenton-like reaction may also contribute to the killing effect of
hypochlorite from the DC treatment. Furthermore, the concentration of intercellular labile iron in
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mammalian cells (1µM) 34 are 10 – 100 times lower than bacterial cells (10 - 100 µM) 35, 36, which
could promote the selectivity of the DC treatment to biofilm cell over host mammalian cells.
Our results showed that Chromium not only kills bacterial cells by itself in presence of DC but
also form the complex with antibiotic and increase the affinity to target molecules. Compared to
tobramycin alone, a lower cleavage ratio of the reaction was observed when combining chromium
(III) with tobramycin. This effect was also related to the molar ratio of tobramycin to chromium
(III). The samples with the mixtures of tobramycin and chromium (III) at 1:1 ratio had the lowest
cleavage ratio, which increased to 2:1 and 10:1. This is consistent with our previous finding that
the chromium (III) (tobramycin) complex was more stable when tobramycin and chromium (III)
were mixed at 1:1 ratio. The cleavage ratios of chromium (III) alone were slightly higher than
tobramycin alone and did not show any obvious changes despite the concentration of chromium
(III). This suggested that chromium (III) had a potential inhibitory effect since it can also bind to
RNA molecules by Coulomb force, and then interfere with the interaction between ribozymes and
substrate RNAs. Generally, chromium (III) had an enchanting effect for tobramycin at 1:1 mole
ratio in hammerhead ribozyme cleavage reaction, which could reduce the ratio of cleavage to 25%
of the positive control. Chromium (III) alone also showed the inhibitory effect in the reaction,
which was slightly weaker than tobramycin alone. The concentration of tobramycin and chromium
(III) were 10 to 100 folds higher than the amount used in our previous studies

12, 13

. These

concentrations were also used in other research with hammerhead ribozyme-catalyzed cleavage
systems, which suggests that higher concentration of antimicrobial agents is necessary to obtain
“observable” results.
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5.6 Conclusion
In summary, we tested the killing effect of different treatment conditions to P. aeruginosa cells
and explored the affinity of tobramycin-chromium (III) complex to RNA molecules in this study.
According to the results, we found that the bactericidal effect came from the hypochlorous acid
generated when using TGON electrodes during DC treatment, while stainless steel electrodes
generate the free radicals as Fenton reaction products between metal ions and hydrogen peroxide
to eradicate biofilm cells. Moreover, chromium ions may play the more important role than ferric
ions during DC treatment since it only initiates Fenton reaction with hydrogen peroxide but also
forms a complex with some antibiotic molecules and enhance its affinity to the target, e.g. RNA.
These findings provide more information for designing better devices in the future.
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5.8 Figures

Figure 1. Viability of P. aeruginosa biofilm cells after treatment in saline solutions with different
concentrations of NaCl (with 30 µA/cm2 DC, TGON electrodes) and NaOCl solution (without
DC).
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Figure 2. Viability of P. aeruginosa biofilm cells after treatment in saline solutions with different
concentrations of NaCl (with 30 µA/cm2 DC, TGON electrodes) and H2O2 solution (without
DC).
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Figure 3. Viability of P. aeruginosa biofilm cells after treatment with 30 µA/cm2 DC in 0.85 %
NaCl solution in dual chamber system with TGON electrodes.
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Figure 4. Viability of P. aeruginosa biofilm cells after treatment with 30 µA/cm2 DC in 0.85 %
NaCl solution in dual chamber system with stainless steel electrodes.
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Figure 5. Viability of P. aeruginosa planktonic cells after treatment with Cr (III) alone (10 µM),
DC (60 µA/cm2) alone or concurrent treatment for 1 h in 0.001% NaCl solution
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Figure 6. Viability of P. aeruginosa planktonic cells after treatment with Cr (III) alone (100
µM), DC (60 µA/cm2) alone or concurrent treatment for 1 h in 0.001% NaCl solution.
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Figure 7. Viability of P. aeruginosa planktonic cells after treatment with Cr (III) alone (10 µM),
DC (20 µA/cm2) alone or concurrent treatment for 1 h in 0.1 % NaCl solution in dual chamber
system.
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Figure 8. Representative images of agarose gel with embedded S. aureus planktonic cells after
being treated with 60 µA/cm2 DC for varying duration of time.
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Figure 9. Living/Dead images of S. aureus planktonic cells in the agarose after DC treatment.
(A)&(B): The cells in the precipitation band region. (C)&(D): The cells outside of the precipitation
band region. (E): The untreated planktonic cells mixed with the precipitates produced by DC
treatment. (F): The untreated planktonic cells.
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Figure 10. Cleavage of substrate RNA by the hammerhead ribozyme. Only the fluorescently
labeled RNA was visible. The upper bands were un-cleavage substrates and lower bands were
cleavage products. From left: 1) Negative control (reference band); 2) Positive control; 3-5) Cr3+
alone (320 µM, 160 µM, 32 µM); 6-8) Mixture of Cr3+ and tobramycin (Cr3+: 320 µM, 160 µM,
32 µM, Tobramycin: 320 µM); 9) Tobramycin alone (320 µM).

This figure has been published in Acta Biomaterialia. Volume 36, May 2016, Pages 286-295.

138

30

Ratio of Cleavage

25

20

15

10

5

0
Neg.
Control

Post.
Control

320μM
Cr3+

160μM
Cr3+

32μM
Cr3+

320μM
160μM
32μM
Cr3+/Tob Cr3+/Tob Cr3+/Tob

Tob

Figure 11. The ratio of cleavage in samples of negative control, positive control, Cr3+ alone (320
μM, 160 μM and 32 μM), a mixture of Cr3+ (320 μM, 160 μM and 32 μM) & tobramycin (320
μM) and tobramycin alone (320 μM).

This figure has been published in Acta Biomaterialia. Volume 36, May 2016, Pages 286-295.
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Chapter 6
Controlling dental plaque with direct current and chlorhexidine

This work has been published in AMB EXPRESS. 7 pp 204 (2017)
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6.1 Abstract
Microbial biofilms formed on biomaterials are major causes of chronic infections. Among them,
Gram-positive bacteria Streptococcus mutans and Staphylococcus aureus are important pathogens
causing infections associated with dental caries (tooth decay) and other medical implants.
Unfortunately, current antimicrobial approaches are ineffective in disrupting established biofilms
and new methods are needed to improve the efficacy. In this study, we report that the biofilm cells
of S. mutans and S. aureus can be effectively killed by low-level direct current (DC) and through
synergy in concurrent treatment with DC and chlorhexidine (CHX) at low concentrations. For
example, after treatment with 28 µA/cm2 DC and 50 µg/mL CHX for 1 h, the viability of biofilm
cells was reduced by approximately 4 and 5 logs for S. mutans and S. aureus, respectively. These
results are useful for developing more effective approaches to control pathogenic biofilms.
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6.2 Introduction
Biofilms are characterized by microbial cells embedded in a matrix comprised of extracellular
polymeric substance (EPS) containing polysaccharide, proteins, and DNA. The presence of this
extracellular matrix provides protection to microbial pathogens from certain antimicrobials and
host immune cells/factors

1, 2

. Biofilms can form on both biotic and abiotic surfaces and are

common causes of chronic infections on implant devices. The protection of EPS plus the dormancy
of biofilm cells render these multicellular structures extremely difficult to eradicate 3-5.
In the previous chapters, we have demonstrated the wireless delivered electric current (DC) could
eradicate pathogen biofilm on polysiloxane surface in vitro and ex vivo, which provides a new
approach to control biofilm-associated infection for electronic medical implants, such as cochlear
device, pacemaker, brain stimulator, et al. As mentioned in Chapter 2, the dental biofilm or dental
plaque) is another serious and common biofilm-associated infections that has bothered people for
thousand years. In this chapter, we investigated if we could also reduce the viability of oral
pathogenic biofilm cells on denture materials with a similar level of DC. The substrate for biofilm
growth in this study was acrylate that is very common denture materials and suitable adhesive
surface for dental pathogens.
Streptococcus mutans is a Gram-positive bacterium commonly found in human dental biofilms. It
is a dominant species with higher biomass in dental biofilms than other Streptococcus species,
including S. sanguinis, S. mitis, and S. salivarius, due to its acid tolerance and thus the capability
to live in low pH environment of oral cavities

6-9

. S. mutans expresses multiple exoenzymes

(glucosyltransferases) that make it the primary EPS producer in oral cavity 9, while it is also highly
acidogenic and aciduric. S. mutans can rapidly colonize tooth surface and establish cariogenic
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biofilms with EPS. This acidifies the local microenvironment and promotes the growth of an
acidogenic microbiota, facilitating the development of dental caries 9, 10.
Staphylococcus aureus is also an abundant Gram-positive bacterium, which usually harbors in the
nasal passages and ears of patients 4. Previous studies have shown that S. aureus is not only the
significant cause of many localized and systemic infections such as osteomyelitis

11

, chronic

wound infection 12, and chronic rhinosinusitis 13 but also has a strong connection to dental implant
infections 14, 15. The established biofilms of S. aureus, especially the methicillin-resistant S. aureus
(MRSA), are highly tolerant to common antimicrobial treatments 16-18.
Few approaches are currently available for controlling cariogenic biofilms 1. Chlorhexidine (CHX)
is considered the “gold standard” for oral antimicrobial therapy 19. However, use of high dose CHX
has adverse side effects such as tooth staining and calculus formation. Also, CHX is not
recommended for long-term daily therapeutic use

20

. In 1994, Costerton et al. (1994) reported

bacterial killing by synergistic effects between low-level electric currents and antibiotics, a
phenomenon named “bioelectric effects”. Since 1990s, direct currents (DCs) ranging from μA to
mA were reported for their bactericidal effects after a relatively long period (from several hours to
days) of treatment 21-24 either by DC alone or with antibiotics together 25-28. Recent studies reported
the mA level DC could enhance the killing effect of 0.2% (200 µg/mL) chlorhexidine on biofilms
of Gram-negative Porphyromonas gingivalis

29

though there was no bactericidal effect by DC

alone. To explore the potential of lower levels of DC and CHX in killing dental biofilms of Grampositive bacteria, we conducted this study with using S. mutans and S. aureus as model species.
We demonstrate that stainless steel electrode derived DC and CHX have strong synergy in killing
S. mutans and S. aureus biofilms, and the levels of DC and CHX are lower than other reported
systems.
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6.3 Materials and methods
6.3.1 Bacteria strains and growth media
S. mutans Clarke strain (ATCC 25175) was cultured in brain heart infusion (BHI) broth (ATCC
medium 44). The S. aureus ALC2085 (strain RN6390 containing pALC2084) was obtained from
the Sauer lab at Binghamton University and cultured in Luria-Bertani (LB) medium 26 containing
10 g/L tryptone, 5 g/L Yeast extract and 10 g/L NaCl, supplemented with 10 µg/mL
chloramphenicol (Sigma-Aldrich, St. Louis, MO, U.S.)

30

. Both strains were routinely cultured

overnight at 37 °C with shaking at 200 rpm.
6.3.2 Biofilm formation
Biofilms were formed on acrylic coupons (3.5 cm x 0.5 cm x 0.1 cm; McMaster-Carr, Aurora, OH,
U.S.). Briefly, 25 µL of an overnight culture of S. mutans was used to inoculate a petri dish
containing 25 mL of BHI medium and acrylic coupons. The culture was incubated at 37°C for 48
h without shaking. Then the coupons with biofilms were removed from petri dish and washed
gently with 0.85% NaCl solution for treatment. The S. aureus biofilm samples were prepared in
the same way except that the medium was LB plus 10 µg/mL chloramphenicol and the incubation
time was reduced to 24 h due to a higher growth rate of S. aureus.
6.3.3 Electrochemical treatment
The experimental system for DC treatment was the same as we described previously (Niepa, et al.
2012; Niepa, et al. 2016). Briefly, an electrochemical cell was constructed with two electrodes on
the opposite sides of a plastic cuvette (Thermo Fisher Scientific, Pittsburg, PA, U.S.). DC was
generated using a potentiostat (Potentiostat WaveNow, Pine Research Instrumentation, Raleigh,
NC, U.S.) in the three electrodes’ configuration system with a silver wire (0.015” diameter, A-M
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Systems, Sequim, WA, U.S.) placed in bleach for 30 min to create Ag/AgCl reference electrode.
The DC level and voltage across the electric field were monitored and recorded using the
AfterMath software (Potentiostat WaveNow, Pine Research Instrumentation, Raleigh, NC, U.S.)
in the galvanostatic mode during the treatment.
6.3.4 DC treatment of biofilms
Each DC treatment was carried out in 3 mL 0.85% NaCl solution. First, one sterile SS304 electrode
(3.5 cm x 0.95 cm x 0.05 cm) was inserted into a cuvette, followed by an acrylic coupon with S.
mutans or S. aureus biofilm attached. Another sterile SS304 electrode was then inserted on the
opposite side. The biofilm was treated galvanostatically with direct current (DC) for 1 h in the
absence or presence of CHX (MP Biomedicals, Solon, OH, U.S.). Samples treated with DC or
CHX alone and untreated samples were used as controls. After treatment, each acrylic coupon was
transferred to a 10 mL tube containing 5 mL 0.85% NaCl solution. The biofilm cells were removed
from the surface by sonication for 1 min. The number of viable cells detached from acrylic coupons
was quantified by counting colony forming units (CFUs) in the solution.
To evaluate the effects in an environment similar to that of oral cavity, the test medium was
replaced with artificial saliva medium or a mixture of 0.85% NaCl and artificial saliva medium
(2:1). The recipe for artificial saliva from Pratten et al. (1998) was followed. It contains 2 g/L yeast
extract, 5 g/L peptone, 2.5g/L type III hog gastric mucin, 0.2g/L NaCl, 0.2 g/L KCl and 0.3 g/L
CaCl2, supplemental with 1.25 mL of sterile 40% urea. The CHX was tested at 50 µg/mL to 500
µg/mL. The treatment process was the same as described above for NaCl solution.
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6.3.5 Live/Dead staining
To corroborate the CFU results, another set of acrylic coupons with biofilms treated with DC and
CHX in the same way were stained with Live/Dead staining kit (Life Technologies Inc., Carlsbad,
CA, U.S.) for 10 min. Then the biofilm samples were imaged using a fluorescence microscope
(Axio Imager M1, Carl Zeiss Inc., Berlin, Germany).
6.3.6 Statistical analysis
Statistical significance was assessed with two-way ANOVA followed by Tukey test. Statistical
signiﬁcance was set as p < 0.05. All the analyses were performed using SAS 9.4 software (SAS
Institute, Cary, NC, USA).

6.4 Results
6.4.1 Effects of DC and CHX on S. mutans and S. aureus biofilms in 0.85% NaCl solution
As shown in Figure 1, treatment with either CHX (at 5, 10, 20 and 50 µg/mL, Figure 1 A) or DC
(at 7, 14 and 28 µA/cm2, Figure 1 B) showed moderate but significant killing. For example, up to
1.2 logs and 0.7 logs of killing was obtained with 28 µA/cm2 DC and 50 µg/mL CHX, respectively.
In comparison, synergy was observed between DC and CHX in killing S. mutans biofilms dosedependently. Among the tested conditions, the maximum killing effect (4 logs) was observed under
the condition of 28 µA/cm2 DC and 50 µg/mL CHX (Figure 1 C & 2 A, p = 0.02, two-way ANOVA
with Tukey test).
Similar synergistic effects were also observed for S. aureus biofilms under the same treatment
conditions. The number of viable S. aureus biofilm cells was reduced by more than 5 logs (Figure
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3 A, p<0.0001, two-way ANOVA with Tukey test) after treatment with 28 µA/cm2 DC and 50
µg/mL CHX for 1 h in 0.85% NaCl solution. In comparison, treatment with the same level of DC
or CHX alone only reduced the number of viable biofilm cells by 60.0 ± 7.9% and 74.3 ± 2.5%
(less than 1 log for both conditions), respectively.
The CFU results were corroborated with fluorescence microscopy. According to the images from
Live/Dead staining of S. mutans and S. aureus biofilms, the number of live cells (green) decreased
when treated with DC and CHX even at low doses (7 µA/cm2 DC and 5 µg/mL CHX for S. mutans,
28 µA/cm2 DC and 20 µg/mL CHX for S. aureus); and almost no live cells (only dead cells show)
were found on the surface of acrylic coupons after concurrent treatment with DC and CHX together
(Figure 4 & 5). Compared with sample treated with DC alone, samples treated with both CHX and
DC concurrently only have patches of cell debris in red, suggesting that substantial cell lysis might
have occurred.
6.4.2 Effects in the presence of artificial saliva
Since the dental surfaces are commonly covered with saliva, we also tested the effects of DC and
CHX in the presence of artificial saliva. When artificial saliva was added to 0.85% NaCl solution
as treatment medium, the killing effects were reduced but still significant. For example, the
reduction of biofilm cell viability was 98.0 ± 0.4% (~1.7 log) when S. aureus biofilm was treated
with 50 µg/ml CHX and 28 µA/cm2 DC in a mixture of artificial saliva and 0.85 % NaCl solution
(1:2 v/v) (Figure S2). No significant killing effect was observed when biofilms were treated in
pure artificial saliva medium under the same dosage of CHX or DC level (data not shown).
However, when the concentration of CHX increased to 500 µg/mL (0.05 w/v %, the dosage used
in commercial oral rising products is 0.12 w/v %) while keeping the DC level at 28 µA/cm2, the
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number of viable S. aureus cells in biofilm was reduced by 2.5 logs compared to untreated control
(Figure 3 B, p = 0.005, two-way ANOVA with Tukey test). The viability of biofilm cells treated
with CHX alone was reduced by approximately 1 log and no significant killing effect was observed
for 28 µA/cm2 DC treatment alone (Figure 3 B). Similar results were observed for S. mutans
biofilms (Figure 2 B and S1), although the killing of S. mutans biofilm cells in artificial saliva
medium was lower than S. aureus. The number of viable cells was reduced by 0.54 log, 0.17 log,
and 1.63 logs when treated with CHX alone, DC alone and concurrent treatment with CHX and
DC, receptively (Figure 2 B, p = 0.02, two-way ANOVA with Tukey test).

6.5 Discussion
Direct currents (DC) and alternative currents (AC) are known to kill biofilm cells in the presence
or absence of antibiotics, and treatment time-tested to date varies from hours to days

22-24

. Our

group recently found synergetic effect between low-level DC and the antibiotic tobramycin in
killing Pseudomonas aeruginosa biofilm and persister cells 26, 27. However, most of the previous
studies focus on biofilms formed on the surface of electrodes.
To mimic real application, it is important to test biofilms that are not in direct contact with
electrodes. In this study, we set a sandwich structure with biofilms formed on acrylic coupons in
the middle of the electric field and about 1.5 mm from each electrode. Our results show that the
viability of S. mutans and S. aureus biofilm cells (placed in between two electrodes) on the surface
of denture material can be reduced by low-level DC and CHX through concurrent treatment in 1
h; and the effect was approximately 1-3 logs stronger than that obtained with the same level of DC
or CHX alone indicating synergistic effects between DC and CHX in killing biofilm cells of these
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two dental bacteria. The effect was more profound in 0.85% NaCl solution than in the artificial
saliva medium. The images of Live/Dead staining also confirmed that there was profound killing
by concurrent treatment.
We speculated that this synergy primarily resulted from the interaction between the products of
DC treatment and CHX. In a recent study, we showed that a large amount of hydrogen peroxide
was generated from electrode surface during DC treatment

26

, which had been reported for its

synergetic antibacterial effect with CHX against Streptococcus and Staphylococcus species

31

.

Furthermore, some metal ions (Zn2+, Cu2+) were shown for their capabilities to enhance the effect
of CHX on different oral pathogens 31, 32. The stainless-steel electrodes used in this study have a
larger surface area and can release multiple types of metal ions including Fe2+, Fe3+, Cr2+, Cr3+ and
Cr6+ during DC treatment 26. Fe2+ and Fe3+ ions were found to kill P. aeruginosa persister cells in
the presence of antibiotics in an electric field

28

. We also found that Cr3+ and Cr6+ can form ion

complex with antibiotic compounds, and thus increase the affinity between antibiotics and
intracellular targets

28

. It is possible that some released ions interact with CHX molecules and

result in the observed synergy in killing S. mutans and S. aureus. This is also part of our ongoing
study.
Recently, Lasserre et al. 29 reported that the viability of P. gingivalis biofilm could be reduced by
81.1% and 98.9% in 10 min when treated with 2000 µg/mL (0.2 w/v %) CHX alone and concurrent
treatment with same dosage of CHX and 5882 µA/cm2 DC, receptively; while the treatment with
DC itself did not kill P. gingivalis cells. The biofilms were cultured on the discs of a Modified
Robbins Device (MRD), which were placed between two electrodes of platinum wires in the
MRD’s chamber. This is an exciting discovery, but the DC level appears high and may not be
suitable for in vivo therapy, especially for the implants closed to nervous systems that do not
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tolerate more than a maximum current density of 30 µA/cm2 33-35. Hence, it is necessary to reduce
DC to µA level for future in vivo application. In this study, we treated S. aureus and S. mutans
biofilm without direct contact to electrodes by placing the acrylic coupon in the middle of the lowlevel electric field and parallel to the electrode surfaces. By using stainless steel as electrode
material, the level of DC and CHX in our study are much lower (28 µA/cm2 DC and 50 µg/mL
CHX), and strong killing effects (3-4 logs) were obtained.
Compared to the 6-7 log killing of P. aeruginosa after 1 h of treatment with DC alone as we
reported previously 26, both S. mutans and S. aureus showed stronger tolerance to a similar level
of DC. Although better killing effect may be archived with longer treatment and higher current
levels, we believe it is better to keep DC treatment duration as 1 h and current level lower than 30
μA/cm2 to minimize the generation of ferric oxide and to avoid the formation of mass hydrogen or
oxygen bubbles.
CHX is bacteriostatic at low concentrations by affecting the integrity of bacterial cell wall and
bactericidal at high concentrations by disrupting the cell 36. S. mutans and S. aureus appear to be
quite susceptible to CHX according to MIC data (< 8 μg/mL) 37. We found that 50 μg/mL CHX
was enough to inhibit planktonic growth completely (data not shown); however, the maximum
killing of preformed biofilms by CHX alone in our experimental system was only less than 1.5
logs even with a dosage up to 500 μg/mL.
Through synergy with DC, CHX was found to be more effective in killing biofilm cells. The doses
of CHX we used were only 50 μg/mL (0.005 w/v %) in 0.85% NaCl solution and 500 μg/mL (0.05
w/v %) in artificial saliva medium, which are much lower than that of commercial products but
still exhibited killing effects with DC. This CHX level is expected to be safe because the

150

commercial products for oral wash have approximately 1200 µg/mL (0.12 w/v %) – 2000 µg/mL
(0.2 w/v %) of CHX. The exact mechanism for such synergistic killing is unknown and is part of
our ongoing research.
This study demonstrated that the DC delivered by wire to treatment facility could eradicate the
dental plaque on the surface of denture material in presence of CHX. This system could also be
modified to satisfy the requirements of wireless DC delivering without any reduction to power
output. The size of receiver coil and controller chip need to be redesigned to fit the narrow space
of oral cavity; however, people have invented the new generation of pacemaker device with a tiny
antenna and an electronic controller for wireless communication. We can utilize a similar design
to integrate the wireless DC treatment facility into the single denture. After being implanted into
the oral cavity, the denture could become a mini DC treatment facility once it receives suitable
magnetic fields.

6.6 Conclusion
In this study, we demonstrated that the biofilm cells of two Gram-positive pathogenic bacteria,
S. mutans, and S. aureus, could be efficiently killed by concurrent treatment with low-level DC
and CHX in 1 h. This electrochemical control is effective against the biofilms formed on the acrylic
materials. The synergistic effect between DC and CHX can help design new devices and strategies
for controlling pathogenic biofilm. The interaction between electrochemical products and CHX
may play a significant role in the observed synergy in biofilm killing, which deserves further study.
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6.9 Figures

Figure 1. Viability of S. mutans biofilm cells after 1 h treatment with CHX alone (A), DC alone
(B) or concurrent treatment with CHX and DC (C). All treatments were tested in 0.85 % NaCl
solution.
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Figure 2. Viability of S. mutans biofilm cells after treatment with CHX alone, DC alone or
concurrent treatment with CHX and DC. A: treatment medium: 0.85 % NaCl, DC level: 28 µA/cm2,
CHX dosage: 50 µg/mL. B: treatment medium: artificial saliva, DC level: 28 µA/cm2, CHX dosage:
500 µg/mL.
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Figure 3. Viability of S. aureus biofilm cells after treatment with CHX alone, DC alone or
concurrent treatment with CHX and DC. A: treatment medium: 0.85 % NaCl, DC level: 28
µA/cm2, CHX dosage: 50 µg/mL. B: treatment medium: artificial saliva, DC level: 28 µA/cm2,
CHX dosage: 500 µg/mL.
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Figure 4. Living/dead staining of S. mutans biofilms treated with 5 μg/mL CHX (B), 7 μA/cm2 DC
(C), 5 μg/mL CHX plus 7 μA/cm2 DC (D) and no treatment (A). Bar = 20 μm.
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Figure 5. Living/dead staining of S. aureus biofilms treated with 20 μg/mL CHX (B), 28 μA/cm2
DC (C), 20 μg/mL CHX plus 28 μA/cm2 DC (D) and no treatment (A). Bar = 20 μm.
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Chapter 7
Wirelessly delivered DC treatment of S. aureus biofilms in a rabbit
model
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7.1 Abstract
Device-associated infection is a serious risk for patients with implant devices, and this risk
becomes more and more significant because of the increasing application of medical devices. The
biofilm on the contaminated device after surgery is reported as a leading cause of infection. The
potent bactericidal activities of direct current (DC) have attracted increasing interest recently. In
Chapter 3, we have demonstrated that the wirelessly delivered direct electric current (DC) could
achieve a good killing effect on Staphylococcus aureus biofilms on the PDMS surface. In this
Chapter, the bactericidal effects of wirelessly delivered DC were further tested on an in vivo model.
The contaminated prototype devices with S. aureus biofilms under the dermis tissue of rabbits and
the biofilms were treated for 6 h with 12 µA/cm2 wirelessly delivered DC. Compared to untreated
controls, treatment with DC reduced the total number of S. aureus within the rabbit by 65 %. In
addition, histological analysis of the dermis and muscle tissues confirmed the safety of wirelessly
delivered DC treatments in the rabbit model.
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7.2 Introduction
From the 1990s, many studies have shown that the potent killing effects of DC on biofilms

1-9

.

These studies demonstrated that the number of viable biofilm cells on the surface of the electrode
or other biomaterials could be reduced by several logs with DC treatment at 10 µA to 100 mA
levels for 1 – 24 h. Furthermore, there have been several successful in vivo anti-biofilm studies
carried in the mice, rodent, rabbit and goat models; however, all of them used wires to deliver
electric current, which had to pierce animals’ skins (Table 1).
Table 1. Bactericidal effects of electric current in vivo
Current/potential Strain

Bactericidal

Animal Antibiotics

level

effect

model

87% reduction

Rodent

-1.8 V vs AgCl

S. aureus

Duration

Ref.

Vancomycin

1h

10

Rodent

Vancomycin

1 h twice

12

(Tissue)
98% Reduction
(Implant)
-1.8 V vs AgCl

S. aureus

2 log reduction
(Implant)

1 mA

P. aeruginosa

58% reduction

Rabbit

Tobramycin

1h

13

100 µA

Staphylococcus

80% reduction

Goat

-

21 days

14

1.5 log reduction

Mice

-

48 h

15

epidermidis
10 MHz low

P. aeruginosa

level AC

As mentioned in Chapters 3 and 4, we have demonstrated that wirelessly delivered DC can
effectively kill S. aureus biofilm cells on PDMS surfaces For example, the viability of S. aureus
biofilm cells was reduced by 3.0 and 2.6 logs using a prototype device to wirelessly delivered DC
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treatment of 6 µA/cm2 in vitro and ex vivo, respectively. These findings motivated us to further
apply this technique in vivo.
To evaluate the safety and efficacy of wirelessly delivered DC in vivo, we conducted an animal
test using a rabbit model. The design was adapted from a previous study of pacemaker material in
a rabbit model, which compared the efficiency of different anti-biofilm coatings pacemaker models
16

.

7.3 Materials and methods
7.3.1 Experimental setup of wirelessly delivered DC treatment in a rabbit model
A total of 8 rabbits were used to compared DC treatment and DC-free control. The control devices
also carried all components in the case, but the electrodes and control modules were discontinued.
Four 1 cm by 0.5 cm S. aureus biofilm samples on PDMS cultured for 24 h in LB medium were
positioned on each device. Each rabbit was implanted with one control and one treatment sample.
Another rabbit was included as biofilm free control, which was also inserted with a DC-free control
and DC-delivering device. This rabbit provided a baseline for histology.
7.3.2 Rabbit model
A total of 9 female adult rabbits (New Zealand, >2 kg each) were involved to investigate the
antibiofilm efficiency of wirelessly delivered DC on S. aureus biofilms formed on implant devices
as well as safety to host tissues. To form the biofilm on the surface of a device, S. aureus cells
were grown overnight in LB medium at 37 °C with shaking at 200 rpm. On the following day, the
overnight culture was used to inoculate 25 ml fresh LB medium with a 1,000 times dilution. Then
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sterilized PDMS coupons (1 x 0.5 cm each) were immersed in the medium and incubated at 37 °C
without shaking for 24 hours. On the following day, PDMS coupons with biofilms were washed
with 0.9% sodium chloride solution twice and then attached on the top the prototype device surface
(around the center anode) in the same way as in vitro setup. The devices with biofilm samples
were kept in petri dishes to ensure moisture.
Before surgery, each rabbit underwent general anesthesia using inhaled 3-5% isoflurane for
induction and 2-4% isoflurane for maintenance. Isoflurane anesthesia was maintained for the
duration of the entire experiment including the implantation of the prototype, wirelessly delivered
DC treatment, and implant removal. A warm blanket was used to help maintain body temperature.
The surgical sites (just a few centimeters lateral to the spine on each side) were identified and
shaved to remove hair. The shaved areas were scrubbed with betadine followed by 75% alcohol
three times. Sterile drapes were placed over the surgical sites. One lidocaine (1%) and 1:100,000
epinephrine was injected to rabbits. An incision on the subcutaneous layer of the skin was made
using a #15 blade, and then the adjacent skin was undermined by scissors to make a pocket cavity.
The prototype device was placed into the pocket and the skin was closed with sutures. The process
was repeated on the contralateral side. Then 30 mL saline solution was injected into each packet
cavity (Figure 1A).
7.3.3 Treatment with wirelessly delivered DC
An electromagnetic transmitter coil connected to the controller chips and USB power cable was
placed over the implant site of prototypes for 6 h of treatment (Figure 1B&C). The DC level was
approximately 200 µA. To minimize the variation among different rabbits, each rabbit was inserted
with two devices including one control (without DC) and one for DC treatment corresponding to
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a current density of 12 µA/cm2 (total 200 µA). During treatment, 30 mL saline solution was
injected into each pocket every 2 hours to keep cavity wet.
7.3.4 Sample collection
After treatment, the incision was opened, and the prototype devices were harvested. Tissue that
had directly contacted with the prototype device was harvested and placed in 10% buffered
formalin, saline solution or frozen directly for future evaluation (Figure 2). After completion of
tissue harvest, the animals were euthanized by an intraperitoneal injection of pentobarbital 150
mg/kg. The PDMS coupons with biofilm were placed in the 0.9% saline solution to determine the
viability of S. aureus.
7.3.5 Histological analysis
To evaluate the cytotoxicity of the wirelessly delivered DC treatment on the dermis layer and
muscle tissue in contact with the device, approximately 20% of the collected skin and muscle
specimens were frozen immediately by ice bath upon harvesting. The specimens underwent
cryosection to obtain the thin film (5 -15 µm of thickness). Then the samples were mounted on
glass slides and Hematoxylin and Eosin staining were performed. Finally, the stained samples were
observed under microscopy to determine if there was any histological change. Another 20% of
collected specimens were kept in 10% buffer formalin solution and sent to IDEXX company to
perform a thorough pathology analysis.
7.3.6 Viability of biofilm cells
About half of the skin tissue that had directly contacted the device and PDMS coupons were
collected after treatment and kept in 0.9% saline solution. Then they were subjected to sonication
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for 1 minute followed by 30s of vortexing. The viability of S. aureus biofilm cells on PDMS
coupons and skin tissue was determined by counting CFU and by Live/Dead staining.
7.3.7 Statistical analysis
Statistical significance was assessed with Wilcoxon Signed Rank Sum Test. Results with p < 0.05
were considered statistically signiﬁcant.

7.4 Results
7.4.1 Experimental design of the treatment by wirelessly delivered DC in vivo
Previous electrochemical studies using animal models aimed to eradicate the biofilm on the surface
of an electrode10, 11. During those experiments, the electrodes were implanted into deep tissue that
contained abundant body fluid (e.g. blood, serum, et al.). The body fluid offers good conductivity
between the anode and cathode, and thus effective killing of bacterial cells. However, our devices
were implanted between the dermis layer and surficial muscle tissue of the rabbit. In this location,
lower amounts of bodily fluids are present compared to the fluid surrounding deeper tissues, which
lower the conductivity for killing biofilm cells on the device surface. The only conductive media
is dermis tissue that has a conductivity of 0.2 S/m 17. To select an appropriate internal resistor and
obtain the current level at the expected range of 200 ± 30 µA, the total current levels and total
impedances between the TGON anode and steel cathode were measured using the same method as
described in Chapter 3. The distance between two electrodes was the same design of the prototype
device, and the electrodes were submerged into 0.1 % saline solution that also has a conductivity
of 0.2 S/m. It found a 10K ohm resistor could maintain the actual total current level at 195 - 210
µA and the working impedance between anode and cathode in 0.2 S/m media was approximately
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15000 Ω (Figure 4). Based on this result, a 10 kΩ internal resistor was included in all prototype
devices. The devices for control samples had the same structure as the devices for DC treatment
although their internal circuits were cut. During the animal test, both control devices and treatment
devices received the same external magnetic field while there weren’t DC output from the control
devices.
7.4.2 Efficacy of wirelessly delivered DC treatment in vivo
To evaluate the efficacy of wirelessly delivered DC treatment in vivo, the prototype devices that
contained four PDMS coupons covered with S. aureus biofilm were inserted under the dermis
layer. Then the biofilm samples were treated with approximately 200 µA DC corresponding to a
current density of 12 µA/cm2 generated by the prototype device wirelessly for 6 hours.
After treatment, the number of viable S. aureus biofilm cells on device surface was reduced by 65%
(p = 0.03), and the number of viable S. aureus cells attached on the skin tissue was reduced to 80%
(p < 0.01) compared to the DC-free control. This suggests that wirelessly delivered DC could
effectively kill the biofilm cells both on the device surface and the surrounding tissue in vivo;
however, the results were not as potent as demonstrated in in vitro tests. There was also some cells
found in the residual liquid (from injected saline) (Figure 3). By adding all three populations
together, it was found that DC treatment killed S. aureus biofilm cells by 66% in vivo (p < 0.008,
Wilcox Signed Ranked Sum Test) (Figure 5).
7.4.3 Safety of the treatment by wirelessly delivered DC
To evaluate the safety of the wirelessly delivered DC treatment, the specimens were collected from
both the skin and muscle tissues surrounding the device for the histological analysis. The result of
this analysis would reveal if DC and its products during treatment could cause acute damage to the
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host tissue. According to the report of histological analysis from IDEXX Bioresearch, there was
no damage specific to treated samples, except for mild infiltration due to surgery that was seen on
both control and treated samples. None of the muscle samples show notable changes.
The skin and muscle samples treated with wirelessly delivered DC underwent cryosection and
Hematoxylin and eosin staining. According to the microscopy images of samples after staining,
there was no significant change between control and treated samples (Figure 6&7).

7.5 Discussion
Electrochemical treatment has been used for orthopedic applications to stimulate the growth of
osteogenic cells on the fracture site 18, 19. Such processes are invasive and require the insertion of
the electrodes to reach into the fracture site. However, electric currents have not been utilized in
clinical for controlling device-associated infections. There were several animal tests on using
electric current to control biofilm formation on the metallic implants, but all of them required
piercing of skin to introduce the wires and deliver electric current from a potentiostat outside the
body to metallic implants.
The animal study in this chapter utilized the wireless delivery technique to replace skin-piercing.
The process of wireless delivering of DC depended on the inductive coupling between two
electromagnetic coils. The alternating magnetic field under our setup could penetrate skin tissue
up to 10 mm, which was sufficient for the in vivo test described here. Further development based
on approach may have promising applications in treating device-associated infections.
During the animal test, it was determined that the under-dermis cavity for the device had to keep
moisture by injecting extra saline solution periodically. Previous animal studies for DC treatment
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were carried in the deeper tissue that had more body fluid (such as blood) that ensures good
conductivity between electrodes. However, we found the cavity under the dermis layer of the rabbit
was very dry. Consequently, the connection between anode and cathode was poor and the actual
current level was much lower than expected. Adding the saline solution could improve the
electrical connection temporarily but it was absorbed by surrounding tissue soon after injection.
Hence, more the saline solution was added every 2 hours in treatment. By testing devices at deep
tissue, we expect stronger antibiofilm activities.
Overall, our results showed that there were three major populations of S. aureus cells in the rabbit
during treatment: the biofilm cells on the PDMS surface, the cells on the skin tissue that attached
to the device and the cells in the residue saline solution in the cavity. For control samples, the total
number of viable cells on skins tissue was almost 10 times higher than cells on PDMS surface.
The number of viable biofilm cells on PDMS were reduced by 75%, and the viability of cells on
the dermis tissue was also reduced by 80% after wirelessly delivered DC treatment. However, the
number of S. aureus cells in saline solution in the cavity varied substantially between tested rabbits.
The average number of these cells showed no significant killing by DC. This is not unexpected
since the volume of residue saline solution was only 100 – 150 µL and stayed in the bottom of the
cavity, which was away from both electrodes. The cells in this region couldn’t be treated by electric
current or electrochemical products. Nevertheless, by counting the total number of cells including
this subpopulation, S. aureus biofilm cells in the rabbit was killed by 65% after wirelessly
delivered DC treatment for 6 hours.
The migration of biofilm cells from PDMS surface to surrounding tissue and liquid in our study
should be due to both animal model itself and the experimental design. The female rabbit skin is
soft but elastic that could attach tightly on the surface of the device after implantation. Meanwhile,
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breathing of the rabbit during the treatment caused “stretch-release” motion, which may generate
shear force and make the skin in close contact with the biofilms. This shear force may peer the
biofilm cells from the device. Another driving force is from the saline solution that was injected
into the implant site. As mentioned above, to keep the cavity and device moisture, we had injected
30 mL saline solution every 2 hours to ensure a good electrical connection. The saline solution
was injected directly onto the surface of the device. This may also cause shear force and wash cells
off from the device’s surface. These would not be of concern if the device were implanted in deep
tissues.
To overcome the barrier of conductivity and improve biofilm killing, it would be helpful to design
implants with conductive material for the case/housing. This can be achieved by infiltrating
conductive materials into the polymer material or coat the device surface with conductive materials.

7.6 Conclusions
In this study, a prototype device with a function of wirelessly delivered DC treatment was tested
in the rabbit model. The S. aureus biofilm cells were treated by the device in the presence and
absence of 12 µA/cm2 wirelessly delivered DC. The most significant killing effect was found on
the cells attached to the dermis tissue, which has high conductivity. The viability of biofilm cells
on devices’ surface was also reduced. For our best knowledge, this is the first study to investigate
the bactericidal activity of the wirelessly delivered DC treatment in vivo although the whole system
still needs optimizing. The results show that wirelessly delivered DC has promising applications
for non-invasive control of device-associated infections.
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7.9 Figures

Figure 1. The setup of the wirelessly delivered DC treatment in the rabbit model. (A): The
prototype device was placed in the pocket under the dermis layer of the rabbit. (B): A transmitter
coils were put on the skin to deliver DC wirelessly. (C): Two rabbits were tested in parallel.
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Figure 2. Representative pictures of the rabbits that were in direct contact with the prototype device.
(A): The skin tissue without DC treatment. (B): A dermis tissue treated with wirelessly delivered
DC for 6 h. (C): The surficial muscle tissue without DC treatment. (D): The surficial muscle tissue
treated with 12 µA/cm2 of wirelessly delivered DC for 6 h.
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Figure 3. Representative picture showing the residue saline solution.
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Figure 4. The total impedances and total current level between anode and cathode in 0.1% saline
solution with different internal resistors.
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Figure 5. Viability of total S. aureus cells in the rabbits after 12 µA/cm2 wireless delivered DC
treatment for 6 h.
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(A)

(B)
Figure 6. HE staining of the dermis tissues in direct contact with the devices. The specimen was
collected, and undergone cryosection. H &E staining was performed to evaluate the histology of
the untreated (A) and treated (B) specimen with 12 µA/cm2 DC wirelessly delivered for 6 h.
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(A)

(B)
Figure 7. HE staining of the surficial muscle tissues in direct contact with the devices. The
specimen was collected, and undergone cryosection. H &E staining was performed to evaluate the
histology of the untreated (A) and treated (B) specimen with 12 µA/cm2 DC wirelessly delivered
for 6 h.
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Chapter 8
Conclusions and Future work
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8.1 Conclusions
Device-associated infections are not only a serious challenge to affected patients but also a heavy
burden for the healthcare system and risk for the development of antibiotic bacteria. Previous
studies discovered the promising killing effects of µA level DC on bacterial biofilms. However,
the approach of DC delivery by wires requires skin piercing and thus limits the application of DC
treatment in vivo. Motivated by this, we conducted this study to investigate the possibility of
applying wirelessly delivered DC treatment to control pathogenic biofilms on the surface of
implanted biomaterial devices. P. aeruginosa and S. aureus were chosen as model pathogens, and
the PDMS was chosen as the substrate for biofilm growth to mimic the contaminated surfaces of
implanted devices. Our results demonstrated for the first time that both P. aeruginosa and S. aureus
biofilm could be effectively eradicated by wirelessly delivered DC. For example, 60 µA/cm2 of
wirelessly delivered DC-mediated with 316L stainless steel electrodes reduced the viability of P.
aeruginosa and S. aureus biofilm cells by 3.6 logs and 2.5 logs, respectively. When using graphitebased electrodes (TGON), similar levels killing effects were obtained with the 30 µA/cm2 of
wirelessly delivered DC. The treatment condition was found safe to lung epithelial cells and
fibroblast cells in vitro.
The killing results based on CFU were corroborated by SEM analysis, which showed that P.
aeruginosa and S. aureus biofilm cells were deformed/lysed after wirelessly delivered DC
treatment. This is consistent with the results of previous researches using wired delivery of DC.
Synergies between wirelessly delivered DC and antibiotics (tobramycin and chlorhexidine) in
killing biofilm cells were also observed.
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To evaluate the potential of wirelessly delivered DC in biofilm control related to commercial
medical implants, we engineered a prototype device with the wireless delivery and treatment
system integrated into prototype device. Different shapes and electrodes layouts of the prototype
device were compared using COMSOL simulation to obtain the best killing effects. In vitro and
ex vivo tests demonstrated good killing effects of the prototype device on both P. aeruginosa and
S. aureus biofilms on the surface of the prototype device. For example, the number of viable S.
aureus biofilm was reduced by 2.3 and 2.1 logs after treatment in vitro and ex vivo for 6 h. These
results demonstrated showed the feasibility of applying the same wirelessly delivered DC
treatment in commercial implant devices (such as cochlear implant, pacemaker, GI tract stimulator,
deep brain stimulator, et al.), which have similar dimension as our prototype device (4.5 cm
diameter, 1 cm thickness).
Although the animal tests showed less killing (65%) effect on S. aureus biofilm cells on the surface
of the device than in vitro and ex vivo tests, because of the low conductivity under the dermis layer,
the wirelessly delivered DC was effective in eradicating S. aureus cells especially those attached
on the dermis tissue without noticeable cytotoxicity. Many researchers reported that the biofilm
on the contaminated implant device could release free cells to the surrounding environment by
shear force and caused secondary infections 1-3. Our results showed that the device of wirelessly
delivered DC treatment could protect both devices and surrounding host tissues from biofilmassociated infections.
Through mechanism study, we found that the products of electrochemical reactions have stronger
effects in biofilm killing than the flow of ions during DC treatment. The killing mechanisms
between the stainless steel electrode and graphite-based electrode appeared to be different. For
example, bacterial killing by DC using graphite electrodes depends on the concentration of sodium
186

chloride in the solution. This concentration-dependent killing effect was also observed when
treating biofilms with different concentrations of the sodium hypochlorite solution. Because the
graphite anode could oxidize the chloride ions to chlorine and hypochlorous acid, the killing effect
of graphite electrodes may be due to its oxidation products during DC treatment. In contrast, steel
electrodes didn’t show any concentration-dependent killing effect, and the hydrogen peroxide
produced by steel electrodes wasn’t enough to cause the killing effects to biofilm. Interestingly,
the killing effect of stainless steel electrode was only observed in the single chamber system. This
indicates that stainless steel electrode has bactericidal agents from the secondary electrochemical
reaction between the products from the anode and cathode, which is completely different from
graphite electrode.
In summary, this study demonstrated that wirelessly delivered DC treatment is a promising
approach for controlling device-associated infections caused by pathogenic biofilms. More
research is needed to further develop this technology for clinical applications.

8.2 Future work
8.2.1 Optimizing the prototype device
The prototype device used in this study has a volume of 25 cm3 that shares a similar size as Oreo
cookie. However, it still seems oversize compared to the latest generation of electronic pacemaker
that is only 1 cm3 4. The smaller size of the device could be more feasible for in vivo applications.
The bottleneck to minify our devices is the rectifier chips and the internal resistor that reduces the
total current to micro-amp levels. The rectifier chip we used is derived from the commercial
wireless electric receiver with several large circuit components and fixed power output (5 V). It is
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necessary to design a new rectifier chip with minimized components to reduce the size and power
output to so that the internal resistor will be unnecessary.
Additionally, the surface conductivity of the device is a critical issue that needs to be considered.
In in vitro and ex vivo tests, the device was perfectly surrounded with a saline solution that
promised good conductivity between the anode and cathode. However, when the device was
implanted in the pocket cavity under the epidermis of the rabbit, it had a drier environment with
only little body fluid. This lead to a poor connection between electrodes, and relating less killing
in the in vivo tests. To address this challenge, the conductive particles (such as carbon black
nanotube and nanoparticle

5, 6

) could be mixed with PDMS monomer to increase the electric

conductivity, and thus the capability of biofilm control by the engineered device.
8.2.2 Roles of the electrochemical products in bacterial killing by DC
Our data indicated that different electrochemical reactions played a significant role in low-level
DC treatment, and the movement of ions does not appear to be important. For example, DC
treatment using graphite electrodes could generate chlorine and hypochlorite, while the steel
electrodes may have secondary electrochemical reactions between anode and cathode products
(Fenton reaction) and produce free radicals. The next step should be using specific assays to
measure the actual concentration of these products in the electrolysis solution. This will provide
deeper insight into the killing mechanism of electric current as well as the information about longterm cytotoxicity.
8.2.3 Wireless electric impendency scanning
The electric impendency scanning (EIS) technique can detect tiny changes in redox property of
the electrode. Thus, it is a perfect approach to monitoring biofilm formation on the surface of an
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implant device. However, conventional EIS also needs wires to connect the potentiostat with
electrodes. If we can modify our system of wirelessly delivered DC treatment to achieve wireless
communication between potentiostat and in vivo electrodes, the device will be able to both detect
the biofilm formation and conduct DC treatment on demand. This would be a new generation of
implanted devices with both self-diagnosing and self-cleaning functions.
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Appendix A. Growing S. aureus biofilm on the PDMS surface of different stiffness
In all the study of this dissertation, we grew the S. aureus biofilm on the stiff PDMS with Young's
modulus of 2 MPa. The actual stiffness of PDMS used in implant device the could be varied. We
reported that the stiffness of PDMS could affect the formation of P. aeruginosa biofilm on early
stage although there was no obvious difference for mature biofilm. To investigate if there was also
such phenomena for S. aureus biofilm, we compared the attachment and growth of S. aureus
biofilm on both stiff and soft PDMS surfaces.
Method:
1. The S. aureus overnight culture was made in the LB medium and then washed by 1X PBS
solution as the same procedure mentioned in Chapter 3. The PDMS surfaces were also prepared
as the same procedure, the ratio of between monomer and crosslinker were 40:1, 20:1 and 5:1 for
soft, medium and stiff PDMS, respectively.
2. The cells’ solution was diluted by 500 times with PBS and then added into petri dish contained
soft, medium and stiff PDMS.
3. The PDMS surfaces were kept in the cells’ solution at 37°C for 2 h.
4. The PDMS surfaces were gently washed with PBS solution and then transported to LB medium
at 37°C.
5. After 2, 5 and 24 hours, the PDMS surfaces were taken out from LB followed by CFU counting
and Living/Dead staining to evaluate the number of viable S. aureus cells.
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Result:
The growth curve of the S. aureus biofilm on PDMS demonstrated that the biofilm on stiff surface
grew obviously slower (Figure 1) in the first 5 hours compared to soft and medium surfaces,
although the numbers of the initially attached cells were same (Figure 2). After 6 hours, the total
cells’ numbers of biofilms on three surfaces were closed, and there was no significant difference
among mature (24 h) biofilms on soft, medium and stiff PDMS surfaces.

Figure 1. The growth curve of S. aureus biofilm on stiff, medium and soft PDMS substrates.
The images of Living/Dead staining were in consistent with the CFU results. For example, there
were noticeably more cells on the soft and medium PDMS surfaces than the stiff one after 2
hours incubation in LB medium although the initially attached cells were almost equal (Figure
3). After 5 hours’ incubation, the soft and medium surfaces had multiple layers of biofilm cells
while the cells’ number of the stiff surface was still closed to initial attachment (Figure 3). After
24 hours’ growth, all three kinds of PDMS surface had similar coverage of biofilm cells.
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Figure 2. The SYTO9 stained S. aureus cells attached on stiff (5:1), medium (20:1) and soft (40:1)
PDMS substrates after inoculation in PBS solution for 2 hours. Scale bars = 20 µm.
In all the studies of this dissertation, the S. aureus biofilms were grown in 22 – 24 hours in LB
medium for 24 hours. At this stage, we didn’t find the significant difference S. aureus biofilm on
soft and stiff PDMS surfaces, which was in consistent with the P. aeruginosa biofilm reported
before. Therefore, the interfere of the substrate’s stiffness could be excluded.
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Figure 3. The SYTO9 stained S. aureus biofilm cells on stiff (5:1), medium (20:1) and soft (40:1)
PDMS substrates during biofilm growth in LB medium. Scale bars = 20 µm.
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Appendix B. Supplementary data Chapter 3: The proof-of-concept study of wirelessly
delivered DC treatment on biofilm cells

Figure S1. The viability of P. aeruginosa (left) and S. aureus (right) planktonic cells after
treatment with 0.06, 0.6 or 6µA/cm2 DC in 0.85 % NaCl for 2, 4 or 6 h.
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